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ABBREVIATIONS
ACC Anterior Cingulate Cortex
ALND Axillary Lymph Node Dissection
Amy Amygdala
ANS Autonomic Nervous System
BDI Beck´s Depression Index
BG Basal Ganglia
BMI Body Mass Index
BrSt Brain Stem
CI Confidence Interval
CIS In Situ Carcinoma
COMT Catechol-O-Methyltransferase
DNIC Diffuse Noxious Inhibitory Control
DZ Dizygotic
HLA Human Lymphocyte Antigen
IC Insula
MDD Major Depressive Disorder




NRS Numerical Rating Scale
OPRM1 Opioid Receptor Mu 1
OR Odds Ratio
PAG Periaqueductal gray
PCA Patient Controlled Analgesia
PFC Prefrontal Cortex
RVM Rostral Ventromedial Medulla
SI Primary somatosensory cortex
SII Secondary somatosensory cortex
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SNB Sentinel Node Biopsy
STAI Spielberger´s State and Trait Anxiety Index
STAXI Spielberger´s State and Trait Anger Expression Index
TENS Transcutaneous Electrical Nerve Stimulation
Th Thalamus
VAS Visual Analog Scale
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ABSTRACT
Breast cancer is the most common cancer among women in the Western world.  In Finland,
approximately 5000 women are diagnosed with breast cancer each year (Finnish Cancer Registry).
Due to advances in treatments, disease prognosis has improved markedly, and increasing numbers
of women have undergone treatment for breast cancer. The quality of life of cancer survivors is a
growing area of research.  Pain after breast cancer treatments is a common adverse symptom.
Depending of the study setting, the prevalence of persistent pain after breast cancer treatments
ranges from 14% to 60%. Both surgery and adjuvant treatments may increase the risk for persistent
pain. The purpose of this prospective study was to identify factors associated with the pain
experience in women treated for breast cancer.  More specific aims were to uncover clinically
feasible factors associated with acute and persistent pain to develop an easy-to-use screening tool
to identify women at the highest risk for persistent pain.
The whole cohort included 1000 patients (18-75 years). They were recruited at the Breast Surgery
Unit of Helsinki University Hospital and were operated on between August 2006 and December
2010. All patients met the research nurse 1-3 days before the surgery. On that preoperative visit,
they filled in questionnaires about medical history, overall health, and pain symptoms. Psychological
symptoms were evaluated by using Beck´s Depression Scale (BDI, depressive symptoms) and the
Spielberger State-Trait Anxiety questionnaire (STAI, state and trait anxiety). Anger regulation was
evaluated by using the Spielberger State-Trait Anger Expression Inventory-2 (STAXI, anger inhibition
and anger expression). Experimental pain tests (cold 4°C and heat 48°C) were performed the day
before surgery. Anesthesia protocol and perioperative pain treatment (oxycodone consumption)
were carefully recorded. Patients documented pain on the first postoperative week (days 1-7) three
times daily in the area of surgery. In the follow-ups (1 month, 6 months, 1, 2, and 3 years after
surgery) patients completed again the same questionnaires about pain, depressive symptoms, and
anxiety.
The range of pain sensitivity between women treated for breast cancer was high. Of the women
treated for breast cancer, 12.6% reported significant pain at six months, and 13.5% had developed
clinically significant persistent pain at the one-year follow-up. The best predictors of pain of any
kind; experimental, acute clinical, or persistent pain, were found to be quite similar. Pain (other
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chronic pain condition, pain in the area of surgery, or intensity of acute pain), more invasive surgery
(axillary clearance), and psychological distress (mainly  anxiety)  were  found  to  be  consistent
predictors of heightened pain experience. In addition to these, pain expectation and higher need
for oxycodone to achieve satisfactory pain relief after surgery were associated with higher pain
intensity during the first postoperative week. Obesity was associated with persistent pain at six
months and one year after surgery. The adjuvant treatments of radiotherapy and chemotherapy
added to the risk for persistent pain at one year.
Screening tools for preoperative and acute phase use to identify women at risk for persistent pain
at six months and at one year after surgery were developed. The one-year prediction tool was also
validated in two other prospective patient cohorts.
The average levels of psychological burden, depressive symptoms, anxiety, and heightened anger
expression or inhibition were surprisingly low. However, there was a group of women whose
distress remained quite stable during the first year. Anger regulation had only a modest association
with pain in this patient cohort, and was influenced by age and mood. However, anger inhibition
was associated with higher depressive symptoms throughout the three-year follow-up. COMT
rs4680 was associated with anger-out.
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TIIVISTELMÄ
Rintasyöpä on naisten yleisin syöpätyyppi maailman laajuisesti. Vuosittain Suomessa rintasyöpään
sairastuu noin 5000 naista (Suomen Syöpärekisteri). Hoitojen kehittymisen myötä eliniän ennuste
sairastumisen jälkeen on noussut huomattavasti. Tämän myötä työssäkäynti-ikäisiä naisia, jotka
ovat sairastaneet rintasyövän, on paljon. Leikkaus on tyypillinen osa rintasyövän hoitoa. Vaikka
leikkaustekniikat ovat kehittyneet ja nykyään selvitään pienemmillä leikkauksilla, siitä huolimatta
leikkauksen jälkeinen pitkittynyt kipu on merkittävä kliininen ongelma. Myös muut rintasyöpään
liittyvät hoidot kuten sädehoito ja solunsalpaajahoidot, voivat vaikuttaa kivun pitkittymiseen.
Tutkimuksesta riippuen pitkittyneen kivun esiintyvyys vuosi rintasyöpäleikkauksen jälkeen vaihtelee
14–60%.
Tämän prospektiivisen tutkimuksen tavoitteena oli selvittää tekijöitä, jotka vaikuttavat kivun
kokemiseen rintasyöpään sairastuneilla ja sen vuoksi hoidetuilla naisilla. Selvitimme tekijöitä sekä
akuuttiin kokeelliseen että kliiniseen kipuun liittyen ja pitkittyneeseen kipuun liittyen. Selvitimme
tekijöitä, joita on kliinisessä työssä mahdollista seuloa.
Aineistomme koostui HYKS sairaalassa leikatuista 18-75 vuotiaista naisista. Aineisto kerättiin
vuosina 2006-2010. Potilaat tapasivat tutkimushoitajan 1-3 päivää ennen leikkausta ja täyttivät
laajasti terveyshistoriaa ja muuta vointia kartoittavia kyselylomakkeita. Psykologisten oireiden
kyselyinä käytimme depressio-oireita kartoittavaa Beckin Depressioasteikkoa (BDI), ahdistusoireita,
sekä tilanteeseen että yleisempää ahdistustaipumusta kartoittavaa Spielbergerin State-Trait (piirre-
ja tilanne) ahdistuskyselyä (STAI) ja suuttumisen ilmaisutyyliä selvitimme Spielbergerin Anger
Expression Inventory-2 kyselyllä (STAXI-2). Potilaille tehtiin leikkausta edeltävänä päivänä myös
kuuma-  (48  °C)  ja  kylmäkipua  (4°  C)  mittaavat  kokeellisen  kivun  testit.  Leikkaukseen  liittyvä
anestesia, sekä akuutin kivun hoito (oksikodonin kulutus) monitoroitiin tarkasti. Potilas kirjasi
ensimmäisen leikkauksen jälkeisen viikon ajan kipua leikkausalueella kolmesti päivässä. Potilaalle
lähettiin kipuun ja osa mielialaan liittyvistä kyselylomakkeista 1kk, 6kk, 1v, 2v ja 3v leikkauksen
jälkeen.
Hoidetuista potilaista 12.6 % ilmoitti kipua leikatulla alueella puolen vuoden seurannassa ja vuoden
seurannassa 13.5 %. Akuuttiin ja pitkittyneeseen kipuun vaikuttavat tekijät olivat melko samanlaisia.
Aikaisempi kipu, joko muu krooninen tai kipu leikattavalla alueella olivat yhteydessä sekä akuuttiin
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että pitkittyneeseen kipuun rintasyöpä leikkauksen jälkeen. Voimakkaampi akuutti kipu leikkauksen
jälkeisinä päivinä ennusti pitkittynyttä kipua vuoden seurannassa. Psyykkinen kuormittuneisuus sekä
voimakkaan leikkauksen jälkeisen kivun odotus vaikuttivat merkittävästi ensimmäisen viikon kivun
määrään. Voimakkaampi tilanneahdistus oli yhteydessä akuuttiin kipuun (kokeelliseen ja
leikkauksen jälkeiseen) ja ahdistustaipumus ennusti pitkittynyttä kipua. Leikkaustyyppi (kainalon
tyhjennys imusolmukkeista) oli yhteydessä sekä akuuttiin että pitkittyneeseen kipuun. Pitkittynyttä
kipua vuoden kohdalla ennustivat myös saatu sädehoito ja voimakas ylipaino. Saatujen tulosten
perusteella kehitettiin ja validoitiin helppokäyttöinen seula, jolla voidaan löytää ennen leikkausta
sekä ensimmäisen leikkauksen jälkeisen viikon aikana kerätyn tiedon avulla ne naiset, jotka voivat
olla riskissä kehittää pitkittynyt kipu.
Potilaat olivat keskimäärin ennen leikkausta psyykkisesti varsin hyvinvoivia. Kliinisesti merkittävää
masennusta ja tilanteeseen liittyvää korostunutta ahdistuneisuutta tai yleisempää
ahdistustaipumusta oli melko vähän. Aggression ilmaisu oli hieman tyypillisemmin nuorilla ulospäin
suuntautuvaa, kun taas vanhemmilla suuttumuksen ilmaisua kohdistui sisäänpäin. Sisäänpäin
suuntautuvan suuttumuksen ilmaisun tyylin huomattiin olevan voimakkaasti yhteydessä
depressioon kolmen vuoden seurannassa. Suuttumuksen ilmaisutyylillä oli vain vähäinen vaikutus
kipuun rintasyöpäpotilailla, lisäksi mieliala ja potilaan ikä vaikuttivat yhteyteen. COMT (rs4680 )
geenillä huomattiin yhteys suuttumuksen ulospäin suuntautuvaan ilmaisuun.
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1. INTRODUCTION
Breast cancer is the most common cancer in women in Western countries, also in Finland (Global
Burden of Disease Cancer Collaboration et al., 2016; Finnish Cancer Registry). Pain is not a typical
symptom that would lead to breast cancer diagnosis, but pain related to breast cancer treatments,
especially  breast  surgery,  is  common  (Wang  et  al.,  2016;  Andersen  &  Kehlet,  2011).  Since  the
number of women who will undergo surgery for breast cancer each year is high, approximately 5000
women in Finland, many will face the risk of persistent pain.
Both acute and persistent pain is always subjective, but also a multidimensional phenomenon,
including physiological and psychological aspects. According to the International Association for the
Study of Pain (IASP), pain is “an unpleasant sensory and emotional experience associated with actual
or potential tissue damage, or described in terms of such damage”. The fundamental function of
acute pain is to inform a person of a plausible danger. Pain experience related to malignant disease
may therefore be different from pain of benign cause. Pain after cancer diagnosis may always
remind a person of the serious disease and therefore underlie the threat message of pain. When
pain is in transition from an acute to a persistent state, the threat value of pain becomes
inconsequential. Psychological factors, especially symptoms of depression and anxiety, are known
to be associated with increased pain experience (Edwards et al., 2016). These psychological
symptoms are also very natural reactions to cancer diagnosis. This combination contributes to how
a person interprets and adapts to pain stimuli. Previous experiences of pain and expectations of
pain are also known to influence pain (Colloca & Benedetti,  2006;  Bingel  et  al.,  2011;  Pan et  al.,
2013). Apkarian et al. (2005) have shown that anticipation of pain is not only a cognitive construct
but a neural process that has an influence on pain.
Psychological distress comprising depressive symptoms and anxiety and also the prevalence of pain
are higher in women. Therefore, the study of the association between pain and psychological factors
in women, especially breast cancer patients, is justified.
Research of factors associated with pain experience in breast cancer patients is important in order
to diminish individual suffering and also economically (Gustavsson et al., 2012), as severe persistent
pain may cause considerable disability and inability to work. It is important to understand the great
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variety of pain sensitivity but also to find factors common to the risk of high intensity of clinical acute
pain and its persistence. With increased knowledge, we are able to develop treatments,
psychosocial and pharmacological, to prevent pain or at least to diminish suffering and to improve
the pain treatment and the quality of life after breast cancer treatments. Moreover, the knowledge
of how common the symptom of pain is among breast cancer patients and who is at risk for pain is
important to enhance healthcare professionals’ awareness of pain and its adequate treatment.
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2. REVIEW OF THE LITERATURE
2.1. BREAST CANCER
In 2014, there were 5008 new breast cancer cases in Finland (Finnish Cancer Registry), compared
with 2802 cases in 1994 and 3929 cases in 2004 (Figure 1).
Figure 1. Increase in the prevalence of breast cancer over a 60-year period.
The risk of having breast cancer increases with age, and part of the rapid rise in incidence is
explained by aging of the population. But even if new incidences are standardized by age, the annual
number of women facing a diagnosis of breast cancer is increasing. Thanks to improvements in
breast cancer treatments over the past decades (Global Burden of Disease Cancer Collaboration et
al., 2016), the survival rates of breast cancer have improved remarkably. The survival rate in Finland
at ten years after the diagnosis is 85% (Finnish Cancer Registry). Therefore, the negative
consequences related to breast cancer treatment and their significance for the quality of life post-
recovery are increasingly important.
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2.1.1. TREATMENT
The severity of breast cancer defines the treatment needed. The TNM classification comprises
information about size of the tumor (T), presence of positive lymph nodes (N), and metastases (M).
In  situ  carcinoma  (CIS)  is  a  local,  early  stage  breast  cancer  where  the  malignant  cells  have  not
penetrated  the  cell  membrane.  Also,  the  grade  of  the  tumor  (1-3)  affects  the  decision  of  the
treatment assigned to a patient. The grade reflects the difference in the appearance of the cancer
cells compared with normal breast tissue. Grade 1 is the cell type closest to normal tissue, and grade
3 is the cell type with the worst prognosis.
2.1.1.1. Breast surgery
Surgery is the primary and the most typical treatment for breast cancer. Its purpose is to remove
malignant tumor from the breast and positive lymph nodes from the axilla, if needed. During breast
surgery sentinel lymph node biopsy (SNB) is performed to determine whether the cancer has
invaded the lymph nodes. Axillary lymph nodes (ALN) on the side of the tumor are usually the first
targets of metastasis and therefore important for diagnosis. Type of surgery in the breast is either
breast-conserving or mastectomy. If the tumor is < 3 cm (Joensuu et al., 2013) and it is possible to
remove entirely from the tissue, then the type of surgery is breast-conserving. Mastectomy,
amputation of the entire breast, is needed if the tumor is large or if there are several cancer tumors
in the breast (multifocal tumor) and they are situated widely apart from each other. Mastectomy is
usually done if the risk of cancer recurrence is high according to the tumor specimen and if the
patient is aged under 35 years. Type of surgery in the axilla is either only sentinel node biopsy (SNB)
or also axillary lymph node dissection (ALND). If the tumor has invaded the lymph nodes, axillary
clearance is needed. This means removal of the axillary fat tissue and those lymph nodes that have
tumor cells.
2.1.1.2. Adjuvant oncological treatment
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2.1.1.2.1. Chemotherapy
Medical adjuvant treatments are recommended if tumor cells are found in the axillary lymph nodes
or if there are metastases elsewhere in the body or if the risk of recurrence is increased.
Chemotherapy is a systemic treatment and usually administered intravenously in the clinic. The
purpose of chemotherapy is to eliminate cancer cells that may have circulated into the blood system
and to parts of the body other than where the original tumor was located. Chemotherapy may be
delivered with a single drug or with a combination of different drugs. Commonly used drugs are
taxanes, anthracyclines, and CEF or CMF combination. The combinations include cyclophosphamide
(C), fluorourasimide (F), epirubisine (E), or metotreksatite (M). If the tumor is HER2-gene positive,
the LHRH agonists, tratutsumab, is used as an adjuvant treatment. Possible long-term side effects
of chemotherapies include cardiomyopathy, neutropenia, and neuropathic pain.
2.1.1.2.2. Radiation therapy
Radiation therapy is a local treatment and the majority of women receives it after breast cancer
surgery as an adjuvant treatment. When the visible tumor is removed from the breast, there may
be malignant cells left and radiation therapy is given to minimize the risk of local recurrence. The
treatment is ionizing radiation and its purpose is to damage the DNA of the cancer cells, which leads
to cellular death. If the tumor has invaded the axillary lymph nodes, radiation therapy is also given
to the axillary area. The most common side effects related to radiation therapy are local erythema,
skin irritation, and pain in the area of radiation.
2.1.1.2.3. Endocrine therapy
Some breast cancer cell types use estrogen in order to multiply. In these hormone-positive cancer
types, endocrine therapy can be used either alone or after other adjuvant treatments. Endocrine
treatment may include antiestrogens or aromatase inhibitors or combinations of both. These are
orally administered and treatment usually lasts five years or even longer. The purpose is to minimize
the risk of recurrence. The most commonly reported side effects for endocrine therapy are sweating
and pain in the joints. Also risk of thrombosis and osteoporosis are known side effects.
2.1.1. TREATMENT
The severity of breast cancer defines the treatment needed. The TNM classification comprises
information about size of the tumor (T), presence of positive lymph nodes (N), and metastases (M).
In  situ  carcinoma  (CIS)  is  a  local,  early  stage  breast  cancer  where  the  malignant  cells  have  not
penetrated  the  cell  membrane.  Also,  the  grade  of  the  tumor  (1-3)  affects  the  decision  of  the
treatment assigned to a patient. The grade reflects the difference in the appearance of the cancer
cells compared with normal breast tissue. Grade 1 is the cell type closest to normal tissue, and grade
3 is the cell type with the worst prognosis.
2.1.1.1. Breast surgery
Surgery is the primary and the most typical treatment for breast cancer. Its purpose is to remove
malignant tumor from the breast and positive lymph nodes from the axilla, if needed. During breast
surgery sentinel lymph node biopsy (SNB) is performed to determine whether the cancer has
invaded the lymph nodes. Axillary lymph nodes (ALN) on the side of the tumor are usually the first
targets of metastasis and therefore important for diagnosis. Type of surgery in the breast is either
breast-conserving or mastectomy. If the tumor is < 3 cm (Joensuu et al., 2013) and it is possible to
remove entirely from the tissue, then the type of surgery is breast-conserving. Mastectomy,
amputation of the entire breast, is needed if the tumor is large or if there are several cancer tumors
in the breast (multifocal tumor) and they are situated widely apart from each other. Mastectomy is
usually done if the risk of cancer recurrence is high according to the tumor specimen and if the
patient is aged under 35 years. Type of surgery in the axilla is either only sentinel node biopsy (SNB)
or also axillary lymph node dissection (ALND). If the tumor has invaded the lymph nodes, axillary
clearance is needed. This means removal of the axillary fat tissue and those lymph nodes that have
tumor cells.
2.1.1.2. Adjuvant oncological treatment
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2.2. PAIN
2.2.1. NOCICEPTION, MODULATION, AND EXPERIENCE OF PAIN
The definition of pain by the International Association of the Study of Pain (IASP) is the basis of the
conception of the nature of both acute and persistent pain experience. According to that definition
pain is “an unpleasant sensory and emotional experience associated with actual or potential tissue
damage, or described in terms of such damage” (Merskey & Bogduk, 1994). Experience of pain is
always a complex interplay between the somatosensory output from the nociceptors to the brain
and the individual modulatory system that determines the actual experience of pain. Therefore,
nociception alone is not necessary or even sufficient for complex pain experience. The foundation
of the theory of the relevance of this modulatory system was described already in 1965 by Melzac
and Wall when they introduced the gate control theory (Melzack & Wall, 1965). The fundamental
idea was that pain transmission from the peripheral nerves through the spinal cord was modulated
by both intrinsic neurons and controls emanating from the brain. Therefore, pain experience could
be controlled by modulation, and this could be done by reducing excitation or by increasing
inhibition. This theory has been tested over the years and its applications are still used in modern
pain treatment. For instance, treatment like TENS (Transcutaneous Electrical Nerve Stimulation)
basically activates large diameter afferents (responsible for e.g. touch and vibration sensations),
which increases the inhibitory effect of interneurons. And this non-painful stimulus decreases pain
sensation through interaction between neurons having large and thin diameters, projection
neurons, and inhibitory interneurons (Melzack & Wall, 1965). In the 16th century, the philosopher
Renè Descartes described pain as a bottom-up ascending sensation without any control along the
way. Figure 2 shows a variety of factors that modern pain research knows to contribute to the
descending top-down pain modulation.
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Figure 2. Factors involved in the descending modulation of pain experience.
With advances in techniques to study brain activation during the actual pain experience, the
dynamic process that influences pain perception has been elucidated (Lee & Tracey, 2013; Martucci
& Mackey, 2016; Tracey, 2017). Understanding of the neural basis of pain has increased, and it is
clear that pain perception is centrally mediated (Tracey, 2008). Pain perception or the experience
of pain is not modified by a specific pain area in the brain, but rather by a pain matrix consisting of
a network of brain areas contributing to the process (Figure 3) (Lee & Tracey, 2013; Melzac, 1999;
Tracey, 2008). Furthermore, pain processing is dynamic, showing a wide variety between
individuals, especially in the case of persistent pain (Denk et al., 2014; Lee & Tracey, 2013; Tracey,
2008).
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Pain experience is modulated through a descending pain modulatory system. Nociceptive
information from the periphery goes through the spinothalamic tract, consisting of the central
nervous system, the spinal cord (largely within the dorsal horn), and the thalamus (Apkarian et al.,
2005; Tracey & Mantyh, 2007). The brainstem area connects nociception with the autonomic
nervous system (ANS) and homeostatic processes (Tracey & Mantyh, 2007). Descending modulation
can produce either facilitation (pronociception) or inhibition (antinociception) (Tracey & Mantyh,
2007). Brain areas contributing to the descending modulation consist of many regions, e.g. the
frontal lobe, insula, anterior cingulate cortex (ACC), amygdala, hypothalamus, periaqueductal gray
(PAG), rostral ventromedial medulla (RVM), and nucleus cuneiformis (NCF) (Lee & Tracey, 2013).
The brain areas important in pain modulation are also involved in mood regulation and emotional
and cognitive experiences (Figure 2). This has been suggested in part to explain the close connection
between psychological factors and pain experience, especially in persisting pain (Bushnell et al.,
2013; Mansour et al., 2014). Multiple psychological factors, e.g. cognitive processing, mood, and
emotional regulation, influence the descending pain modulation (Figure 3) (Apkarian et al., 2005;
Bushnell et al., 2013; Denk et al., 2014; Goffaux et al., 2007; Millan, 2002; Tracey, 2010). Structural
anatomical changes in the brain have been reported across different clinical pain conditions when
pain persists for a long time (Baliki et al., 2014). Interestingly, these changes have been found to be
reversible after adequate pain treatment (May, 2011).
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Figure 3. Pain  networks  in  the  brain.  Descending  pain  modulation  and  brain  areas  that  are  also
important in emotions and mood, e.g. depression and anxiety (green), and cognitive regulation, e.g.
expectancy (blue), have been circled. SI = primary somatosensory cortex, SII=secondary
somatosensory cortex, MI =primary motor cortex, ACC = anterior cingulate cortex, IC = insula, PFC =
prefrontal cortex, Th = thalamus, BG = basal ganglia, Amy = amygdala, BrSt=brainstem (Figure is
modified from Vartiainen and Forss 2014. Duodecim,130:1507-14 and reproduced with permission
from Duodecim).
Wide variety of neurotransmitters are also involved in this regulation (Millan, 2002). Serotonin may
either facilitate or inhibit descending modulation (Millan, 2002), whereas norepinephrine released
from the dorsal horn is connected to descending inhibition (D'Mello & Dickenson, 2008; Millan,
2002). Also, the role of e.g. endocannabinoids (Zogopoulos et al., 2013), endogenous opioids,
acetylcholine, and substance P in descending pain modulation are well acknowledged (Millan,
2002).
One explanation for altered pain sensation is central sensitization. It is described as an increased
functioning of neurons and circuits in nociceptive pathways, leading to pain from a non-painful
stimulus or an excessive perception of pain from low-level painful stimuli. It has been suggested to
eventually lead to neuronal plasticity of the peripheral and central nervous system. The altered
tissue sensitivity can be seen within the injured area, but also in uninjured tissue around the injury
(Latremoliere & Woolf, 2009; Woolf, 1983).
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Decades of pain research and findings in clinical work with pain patients suggest that also more
psychosocial components of pain should be added to the definition of pain (Williams & Craig, 2016).
Pain is generally an emotional experience that causes suffering and widely affects the patient’s life.
Williams and Craig (2016) have suggested that the definition of pain should therefore also include
social  and  cognitive  components.  Because  pain  is  such  a  complex  issue,  it  is  difficult  to  assess,
manage, and treat.
2.3. PAIN SENSITIVITY
Sensitivity to pain differs enormously among individuals (Edwards, 2005; Mogil, 1999). The same
surgical procedure or other painful stimuli are reported differently, and pain experiences from the
same stimuli are not comparable. Variation between individuals within the same painful condition
has been stated to be greater than the differences across painful conditions (Nielsen et al., 2009).
The definition of pain sensitivity is not clear and it seems to vary within an individual depending on
the modality of pain (Nielsen et al., 2009). Pain sensitivity can be studied in a well-controlled
experimental pain setting where the intensity of noxious stimuli is the same across tested subjects
(Edwards, 2005).
2.3.1. MEASURING PAIN
Since pain is a highly subjective and multidimensional experience, self-report is the gold standard
for its measurement. This obviously has limitations and it could be argued that the differences
between individuals not only reflect actual differences in physical pain sensation but also individual
reporting style and usage of the pain rating scales. These issues have been of interest in pain
research. A brain imaging study, performed with healthy participants, showed that those individuals
reporting high pain ratings in an experimental pain test activated more frequently and with a greater
magnitude the brain regions responsible for processing pain-related information (Coghill et al.,
2003). These findings are thought to be a neural proof of individual differences in pain experiences.
New suggestions about how to image pain with advanced brain image techniques have inevitably
yielded more information about pain processes, but these cannot replace the subjective evaluation
given by the person experiencing the pain (Robinson et al., 2013).
2.3.1.1. VAS and NRS
Sensory intensity is the most commonly assessed aspect of pain. The Visual Analog Scale (VAS) and
Numerical Rating Scale (NRS) have been shown to be equally reliable estimators of the intensity of
especially acute pain (Breivik et al., 2008). The NRS is a commonly used measure in both clinical and
research settings, and it has shown good validity when measuring pain intensity in various age
groups (Fillingim et al, 2016; Gagliese et al., 2005). It has also been demonstrated to have good
reliability and stability across experimental sessions (Rosier et al., 2002).  It is an 11-point Likert scale
ranging from 0 to 10 where zero indicates “no pain” and 10 “the worst imaginable pain”. NRS cut-
off point ≥4/10 has been shown to identify patients with moderate to severe pain in postoperative
pain (Gerbershagen et al., 2011). Despite good overall validity, NRS may be prone to biases. Smith
et al. (1998) noted in their study with cancer patients that if a patient attributed her/his pain to
cancer their estimation of pain was higher than those who did not.
2.3.1.2. Patient-controlled analgesia (PCA)
Patient-controlled analgesia (PCA) can be used as a proxy for the intensity of postoperative pain.
The need for analgesics postoperatively is an indirect but clinically relevant way to measure
individual sensitivity to pain (Kissin, 2009). However, in addition to pain intensity, there are number
of factors that may affect the behavior how a patient uses PCA. For example, younger age (Saari et
al., 2012) and psychological variables, e.g. depressive symptoms (De Cosmo et al., 2008) and anxiety
(Pan et al., 2006; De Cosmo et al., 2008), have been found to be associated with more frequent
demands for opioid doses. In a study with patients operated on mainly for a malignant cause,
attentional avoidance of emotionally negative stimuli was found to predict a higher amount of
demands (Lautenbacher et al., 2011).
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yielded more information about pain processes, but these cannot replace the subjective evaluation
given by the person experiencing the pain (Robinson et al., 2013).
2.3.1.1. VAS and NRS
Sensory intensity is the most commonly assessed aspect of pain. The Visual Analog Scale (VAS) and
Numerical Rating Scale (NRS) have been shown to be equally reliable estimators of the intensity of
especially acute pain (Breivik et al., 2008). The NRS is a commonly used measure in both clinical and
research settings, and it has shown good validity when measuring pain intensity in various age
groups (Fillingim et al, 2016; Gagliese et al., 2005). It has also been demonstrated to have good
reliability and stability across experimental sessions (Rosier et al., 2002).  It is an 11-point Likert scale
ranging from 0 to 10 where zero indicates “no pain” and 10 “the worst imaginable pain”. NRS cut-
off point ≥4/10 has been shown to identify patients with moderate to severe pain in postoperative
pain (Gerbershagen et al., 2011). Despite good overall validity, NRS may be prone to biases. Smith
et al. (1998) noted in their study with cancer patients that if a patient attributed her/his pain to
cancer their estimation of pain was higher than those who did not.
2.3.1.2. Patient-controlled analgesia (PCA)
Patient-controlled analgesia (PCA) can be used as a proxy for the intensity of postoperative pain.
The need for analgesics postoperatively is an indirect but clinically relevant way to measure
individual sensitivity to pain (Kissin, 2009). However, in addition to pain intensity, there are number
of factors that may affect the behavior how a patient uses PCA. For example, younger age (Saari et
al., 2012) and psychological variables, e.g. depressive symptoms (De Cosmo et al., 2008) and anxiety
(Pan et al., 2006; De Cosmo et al., 2008), have been found to be associated with more frequent
demands for opioid doses. In a study with patients operated on mainly for a malignant cause,
attentional avoidance of emotionally negative stimuli was found to predict a higher amount of
demands (Lautenbacher et al., 2011).
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2.3.1.3. Experimental pain
Experimental pain testing is a commonly used setting to explore individual and interpersonal
variance in pain experience. The experimental setting uses controlled noxious stimuli, e.g. thermal
(cold or heat), mechanical (blunt pressure or sharp), or chemical (e.g. capsaicin), that represent
different modalities of pain. Traditionally, two features are measured: pain threshold and pain
tolerance. Threshold measures the point where an individual reports the stimulus as painful. In the
experiment, the stimulus usually is initially a non-painful sensory perception, with the stimulus
intensity increasing until it reaches a painful level. Pain tolerance describes the maximum time a
person can tolerate the pain stimulus. The intensity of suprathreshold pain is also used to measure
pain sensitivity. This reflects the intensity that an individual reports beyond his/her pain threshold.
Temporal summation of pain is a dynamic measure of pain sensitivity. It has been considered to
reflect the central sensitization of pain in a situation where experimental pain stimulation is given
repetitively, with the difference between the pain evoked after one stimulus and the amount of
pain evoked after a series of pain stimuli calculated (Arendt-Nielsen et al., 1995). The physiological
mechanism behind temporal summation is the activation of N-methyl-D-aspertate (NMDA)
receptors as a result of high levels of nociceptive input. In a clinical condition, this is seen as allodynia
and hyperalgesia (Arendt-Nielsen et al., 1995).
Another dynamic measure of pain sensitivity is the Conditioned Pain Modulation (CPM) experiment.
It comprises psychophysiological tests believed to represent diffuse noxious inhibitory control
(DNIC) and to reflect the altered function of the endogenous pain inhibitory pathway (Shrout &
Fleiss, 1979; Yarnitsky et al., 2015). The idea is that “pain inhibits pain”. The experiment could be
done in various ways and different pain modalities can be used. In brief, the procedure consists of
two subsequent painful stimuli, e.g. cold pressure tests. The hypothesis is that the second noxious
stimuli (test part) is experienced as less painful because of an activation of endogenous descending
pain control. The wide range of experimental settings has hindered comparison of studies, and
therefore, a guideline for applying the experiment has been published (Kennedy et al., 2016;
Yarnitsky et al., 2015). Nevertheless, various studies have concluded that low efficiency in DNIC is
associated with both acute and persistent postoperative pain (Yarnitsky, 2010).
It would be a very tempting idea that clinical postoperative pain could be predicted by the level of
experimental pain sensitivity. There is no clear understanding of what experimental pain modalities
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best predict clinical pain sensitivity (Abrishami et al., 2011). The results of the comparability
between experimental pain and clinical pain have been controversial. Kim et al. (2004) did not find
predictive value of experimental (thermal or cold) pain ratings on pain after oral surgery, whereas
Nielsen et al. (2007) found that lower pain threshold for electrical pain was associated with higher
pain ratings after Cesarean section. Pan et al. (2006) found that heat pain threshold predicted acute
pain  at  rest  after  the  same  procedure.  Also,  Granot  et  al.  (2003)  found  a  positive  association
between experimental pain and Cesarean section acute pain. Their finding was related to a specific
modality, heat pain, and only suprathreshold pain, not pain threshold, predicted acute pain.
Predicting persistent pain with experimental pain testing has yielded conflicting findings (Granot,
2009; Johansen et al., 2014). In a large cohort of surgical patients, the predictive value of decreased
cold pain tolerance to persistent pain disappeared after adjusting the analysis for other chronic pain
conditions (Johansen et al., 2014). Also age has been shown to be related to the sensitivity of cold
pressure pain, with younger healthy volunteers reporting lower thresholds to the pain stimulus than
older participants (Lariviere et al., 2002). One study was performed to assess the predictive value of
the efficacy of DNIC in breast cancer patients. It found no association between DNIC and post-
operative acute pain. However, the authors did find that higher pain intensity in the hot water
experiment was associated with higher acute postoperative pain (Rehberg et al., 2017). Divergent
findings of the association between experimental and clinical postoperative pain (acute or
persistent) reflect well the complex nature of pain. Numerous factors contribute to the intensity of
pain and subsequent disability. For instance, the context in which pain is experienced and reported
(Blasi et. al, 2001), the coping strategies used (de Rooij et al., 2014), and mood (Hinrichs-Rocker et
al., 2009; Chapman and Vierck, 2016) may have strong influence on the pain experience. Therefore,
a more comprehensive preoperative evaluation than experimental pain sensitivity alone is needed
to predict the risk of persistent postoperative pain.
2.3.2. GENETICS
2.3.2.1. Heritability
Heritability may explain some of the interindividual differences in pain sensitivity. The role of genetic
variation in pain sensitivity can be studied in animal models (Lariviere et al., 2002; Mogil et al.,
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1999a; Mogil et al., 1999b). In these models, the social and environmental effect of pain experience
remains stable, since laboratory animals are bred in controlled environments and they lack the
psychosocial history of humans, which is known to have an effect on pain experience. However, the
role of a social environment has been demonstrated also in laboratory mice whose response to pain
stimulus was affected by observation of a cage-mate who was exposed to the same test earlier
(Langford et al., 2006). In humans, the portion of the variance of pain sensitivity explained by genetic
variations can be evaluated with twin studies. Dizygotic (DZ) twins share only 50% of their
segregating genes, whereas monozygotic (MZ) twins are genetically identical. By studying twin pairs
assuming that they share the same environment the importance of genetic factors may be explained
over the variance that is not explained by the environment factors. When examining sensitivity to
experimental pain stimulus, greater similarity for a particular response to a painful stimulus within
MZ twins, compared with DZ twins, can be considered to be due to genetic factors. In a study done
with female twins, heritability for different experimental pain modalities ranged from 22% to 55%
(Norbury  et  al.,  2007).  In  another  study,  including  both  genders,  genetic  variants  explained
approximately the same amount of pain variance:  60% of cold pressure pain and 26% of contact
heat pain (Nielsen et al., 2008). Heritability in chronic pain conditions has also been established. A
large Finnish twin cohort study demonstrated that up to 51% of the fibromyalgia-related symptoms
were explained by heritability (Markkula et al., 2009). Heritability can also be investigated in
population-based studies; e.g. in a study in Scotland the heritability for chronic pain was 38.4%
(McIntosh et al., 2016).
2.3.2.2. Gene variants and pain
The research aimed at identifying specific gene variants to explain differences between individuals
in vulnerability to pain sensitivity and its persistence has been active (Mogil, 2012a; Montes et al.,
2015).  There  is  a  hope  that  with  advances  in  finding  genetic  variants  that  are  related  to  pain,
pharmacotherapies and other treatments could be improved and new targets for drugs could be
discovered. A large challenge has been in replicating different findings in new studies. The difficulty
is that gene variants associated with pain are often either relevant only to a specific modality of pain
rather than to a specific pain condition or the associations are specific to gender or even ethnicity
(Hastie et al., 2012; Mogil, 2012a; Denk et al., 2014). Gene variants responsible for pain modulation
are also often associated with psychological variables related to descending modulation of pain, e.g.
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pain catastrophizing, depression, and anxiety (Bogdan et al., 2013). McIntosh et al. (2016) found in
their wide population-based study that chronic pain and major depressive disorder (MDD) were
positively correlated and the shared genetic variations explained a significant part of the association.
Mogil (2012a) concluded in an extensive review that the most commonly found variants associated
with different pain phenotypes included the gene that encodes the catecholamine catabolizing
enzyme catechol-O-methyltransferase (COMT) (e.g. postoperative pain, cancer pain, and
musculoskeletal pain), μ-opioid receptor gene OPRM1 (e.g. experimental pain and acute pain),
GCH1 that encodes an enzyme called GTP cyclohydrolase (e.g. back pain an experimental pain), and
human lymphocyte antigen (HLA) (e.g. inflammatory pain and neuropathic pain). COMT
metabolizes, for instance, norepinephrine and dopamine and has been shown to moderate, in
addition to pain, also psychological factors such as pain catastrophizing (George et al., 2008),
aggressive behavior, anger regulation (Baud et al., 2007; Rujescu et al., 2003), depression, and
anxiety disorders (Lacerda-Pinheiro et al., 2014). Studies performed in healthy volunteers have
shown that the impact of COMT val158met gene variant on depression- and anxiety-related
emotional processing is more prominent in females (Domschke et al., 2012). Also, associations
between OPRM1, anger expression, and acute pain have been suggested (Bruehl et al., 2008b). De
Gregori et al. (2016) found in their study in patients undergoing abdominal surgery that neither the
need for analgesics nor postoperative pain intensity was associated with one gene variant, but
rather with a combination of different genes.
2.3.3. GENDER DIFFERENCES IN PAIN SENSITIVITY AND EXPERIENCE
It is well known that women report more experimental, acute clinical, and persistent pain (Bartley
& Fillingim, 2013). Women also have a higher prevalence of painful diseases, e.g. fibromyalgia and
irritable bowel syndrome, and report more pain related to these conditions (Bartley & Fillingim,
2013), which may explain a portion of the differences in pain prevalence between genders. There is
fairly good consistency between studies showing that women are more sensitive to different
modalities of experimental pain than men (Mogil, 2012b). This difference has been shown in both
healthy volunteers (Kim et al., 2004) and in patients undergoing a surgical procedure (Johansen et
al., 2014). A study by De Cosmo et al. (2008) found that, compared with men, women reported also
more acute postoperative pain after laparoscopic cholecystectomy. However, in a systematic review
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searching for predictive factors for acute postoperative pain and analgesic use, female gender was
as often positively correlated as negatively correlated with pain (Ip et al., 2009). Some studies also
suggest that gender moderates how different psychological factors, e.g. anger, affects the pain
experience and its reporting (Bruehl et al., 2007; Burns et al., 1998). The explanation for why women
report more pain in general is suggested to be multifactorial and still partly unclear. A wide range
of studies have demonstrated that women have more deficient DNIC than men, although studies
reporting no difference also exist (van Wijk & Veldhuijzen, 2010), but interestingly no studies show
superior DNIC in women (van Wijk & Veldhuijzen, 2010) .
One reason behind the gender differences in pain may be the effect of sex hormones. Rosen et al.
(2017) suggested in their review article that the overrepresentation of women in different painful
conditions and diseases as well as pain persistence may in part be explained by neuroimmunological
factors. They suggested that women may produce a larger proinflammatory immune reaction to
tissue damage (such as surgery) and have more inflammation, leading to higher pain reports (Rosen
et al., 2017). Mast cells, T cells, and macrophages are found to increase the release of
proinflammatory cytokines due to estrogen (Rosen et al., 2017). Testosterone, on the other hand,
has been found to have a more antinociceptive influence on pain (Craft, 2007).
Also, differences in pain-related coping and psychological variables are suggested to explain the
gender differences. Pain-related catastrophizing and rumination is higher in women (Meints et al.,
2016). Both of these are known risk factors related to pain intensity and persistence (Meints et al.,
2016; Keefe et al., 1989). Furthermore, social expectations may also cause bias in pain reporting
(Robinson et al., 2001); men are expected to report less pain than women. Interestingly, healthcare
professionals have been demonstrated to estimate females to have more severe pain than men,
which may lead to different decisions in treatments between the sexes (Alqudah et al., 2010;
Wandner et al., 2010).
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2.4. PSYCHOLOGICAL FACTORS AND PAIN EXPERIENCE
2.4.1 THE BIOPSYCHOSOCIAL MODEL OF PAIN
Psychological factors influence how threatening, intense, or interfering we perceive the noxious
stimuli to be, and, most importantly, how we experience pain. The biopsychosocial model of pain
was developed to describe the multidimensional nature of pain and to converge the dualistic
perspectives of the physical and psychological components of pain. The biopsychosocial model
describes the dynamic process between physiological, psychological, and social components that
mutually influence each other (Gatchel, 2004). The model reflects cancer-related pain well since a
multitude of factors, including medical illness, treatments, and psychological suffering and distress,
are involved in the pain experience (Syrjala & Chapko, 1995).
The meaning of psychological factors, such as depression, anxiety, pain catastrophizing, fear, and
anger, has been the focus of research for already a couple of decades (Bruehl et al., 2006; Burns et
al., 2008; Edwards et al., 2016; Keefe et al., 2004). In addition, cognitive processing, e.g. attentional
mechanisms, hypervigilance, and pain anticipation, has been investigated (Eccleston & Crombez,
1999; Lautenbacher et al., 2011; Pan et al., 2013). The traditionally studied psychological aspects of
how a person experiences pain and adjusts her/his life to persistent pain could be classified as
having a negative valence (Edwards et al., 2016). However, the protective, resilience factors also
have a role in the perception of interfering or disabling pain (Goubert & Trompetter, 2017).
Important components of resilience in persistent pain are suggested to be psychological flexibility,
basic psychological need satisfaction, and positive attitude (Goubert & Trompetter, 2017). These
are thought to be associated with how well  a  person engages in positive coping (de Rooij  et  al.,
2014).
Although the biopsychosocial model of pain is widely supported, it has been criticized for
emphasizing psychosocial features, especially when clear anatomic pathology underlying the pain is
missing (Weiner, 2008). It is important to be aware that psychological factors, e.g. anxiety and fear
related to pain, especially in the acute phase, are mostly normal reactions and normal processing
related to possible danger-causing input, not signs of psychiatric illnesses. Anxiety, depressive
symptoms, negative mood, and pain catastrophizing have previously been shown to be associated
with experimental pain sensitivity (Starr et al., 2010; Strulov et al., 2007; Thompson et al., 2008).
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Heightened anxiety and depression have been found to be associated with more intense acute pain
and with the transition from acute to persistent pain post-surgically (Hinrichs-Rocker et al., 2009;
Chapman and Vierck, 2016).
Psychological factors influence the pain experience and its persistence on many levels; as a risk,
protective or moderating factors. A recent comprehensive review describes the interaction between
psychological vulnerability and resilience factors in persistent pain, and their associations with
neurobiological  pathways  (Denk  et  al.,  2014).  Psychosocial  factors  are  thought  to  heighten  the
process of sensitization at the peripheral, spinal, and/or brain levels through cellular priming,
epigenetic  changes,  and  alterations  in  brains  networks  concerned  with  motivation,  reward,  and
descending modulatory control (Denk et al., 2014). A negative outlook can influence
psychoneuroimmunology (Voscopoulos & Lema, 2010) and the risk of postsurgical complications
(Kiecolt-Glaser et al., 2002; Mavros et al., 2011). An increased psychological burden has been found
to be associated with greater postoperative analgesic requirement (De Cosmo et al., 2008; Pan et
al., 2006), poorer rehabilitation (Leeuw et al., 2007), and lack of engagement in different treatments
(Shelby et al., 2012; Litt & Porto, 2013).
Although anxiety and depressive symptoms have unique features, e.g. sensorimotor hyperarousal
in anxiety and anhedonia in depression (Clark & Watson, 1991), their comorbidity is high (Ball et al.,
2002; Kircanski et al., 2016). The link between psychological factors and pain is acknowledged to be
bidirectional; emotional reactivity and cognitive functions are known to affect pain experience and
its persistence (Williams, 2014; Linton et al., 2011; Asmundson & Katz, 2009), and also a prolonged
pain condition increases the risk for mood disorders and lowers the quality of life (Edwards et al.,
2016; Williams, 2014; Linton et al., 2011; Asmundson & Katz, 2009).
2.4.1.1 Anxiety
Pain naturally consists of an element of fear since its ultimate purpose is to function as an alarm of
a possible danger. Fear motivates the person to the defensive response of avoidance or escape.
When the feeling of fear appears together with physiological, cognitive, and behavioral
components, it forms an affective experience of anxiety (Fernandez, 2002). Fear together with
experience of anxiety informs the individual of a vulnerability, and individual processing to cope
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with anxious arousal varies markedly (Fernandez, 2002).  Anxiety does not merely affect the
physiological reaction to how pain is modulated (Voscopoulos & Lema, 2010), but also influences
the  cognitive  processing  of  pain  (Eccleston  &  Crombez,  1999).  It  seems  that  pain  attracts  more
attention in anxious individuals (Eccleston & Crombez, 1999). Anxiety sensitivity is known to be
associated with an interpretative and negative attentional bias, and this in part explains why anxious
individuals evaluate pain in a more threatening and negative manner and report a more intense
pain experience (Keogh & Cochrane, 2002). The results of neuroimaging studies have shown that
anxiety and negative expectation of pain (nocebo) are close to each other also on a neural level
(Kong et al., 2008). This has been addressed also in clinical studies in which highly anxious patients
were shown to expect  more pain after  Cesarean section (Pan et  al.,  2013).  In  a  study done with
breast cancer patients, where in particular the origin of pain expectations was investigated, high
trait anxiety and preoperative distress were associated with higher expectancy of pain (Schnur et
al., 2007).
Evidence of the association between anxiety and persistent surgical pain is strong. In a review article
including all surgery types, no negative associations were found (Theunissen et al., 2012). Although,
studies reporting no association existed, the majority found that anxiety or pain catastrophizing
were related to pain persistence (Theunissen et al., 2012). Measurement of anxiety varies widely
between studies (Theunissen et al., 2012). Most studies have used measurements of general
anxiety, but also pain-related anxiousness and pain catastrophizing have been of interest
(Theunissen et al., 2012). A meta-analysis comparing different scales used to assess anxiety did not
reveal significant differences in how well these scales predicted the risk of persistent postsurgical
pain (Theunissen et al., 2012). Pain-related catastrophizing is continuously found to be a risk factor
for higher acute or persistent pain experience (Khan et al., 2011; Quartana et al., 2009; Theunissen
et al., 2012). This refers to a tendency to exaggerate and to ruminate on pain experience (ongoing
or anticipated), and to anticipate pain in a more threatening and worrying way. Catastrophizing
belongs to the anxiety spectrum symptoms and is associated with increased awareness of bodily
sensations and heightened attention towards pain (Khan et al., 2011; Quartana et al., 2009).
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2.4.1.2 Pain Expectation
Many different contexts of pain have revealed that the expectation of pain or its relief has an
enormous impact on how the pain is experienced (Lariviere et al., 2002; Bingel et al., 2011; Atlas &
Wager, 2012; Colloca & Benedetti, 2006; Petersen et al., 2014; Tracey, 2010; van Laarhoven et al.,
2011). Pain expectation is an important component of the placebo effect, and neuroimaging studies
have shown a solid neural basis for it and its involvement in descending pain modulation (Figure 3)
(Apkarian et al., 2005; Atlas & Wager, 2012; Eippert et al., 2009; Koyama et al., 2005; Goffaux et al.,
2007). Especially the prefrontal-limbic-brainstem interactions are involved in emotional and
cognitive pain processing (Tracey, 2010). The placebo effect is shaped by a patient’s prior
experiences (Colloca & Benedetti, 2006).  Pain expectancy and placebo effects are concrete
evidence of how psychological variables influence the pain experience. In a clinical study, lower pain
values for an experimental test stimulus were reported in the group told to expect pain relief after
the conditioned pain stimulus (Lariviere et al., 2002). Furthermore, the same study also showed a
reduction in nociceptive-related somatosensory-evoked potentials in the group primed to expect
an analgesic effect in a DNIC condition. Authors suggested that these findings prove the connection
between brain structures involved in expectations and modulation of DNIC effects (van Wijk &
Veldhuijzen, 2010). In another study in healthy subjects, the efficacy of opioid analgesics was
dependent on the expectancy of its efficiency. When the participants were told that the given opioid
infusion was stopped (but was actually still ongoing), its analgesic effect was abolished (Bingel et al.,
2011). The predictive role of pain expectancy on acute postoperative pain reports has also been
demonstrated in patients undergoing Cesarean section (Pan et al., 2013). Montgomery et al. (2010)
found that higher expectation of pain predicted the first week of pain after breast cancer surgery.
Not only negative expectations have found to be associate with poorer pain related outcomes, but
also on the other way around, positive beliefs have found to be related with more positive treatment
outcomes (Wertli et al., 2017).  The close relationship between pain expectations, anxiety (Schnur
et al., 2007; Pan et al., 2013), and hypervigilant behavior towards pain (Keogh & Cochrane, 2002)
could partly explain the impact on individual pain sensitivity.
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2.4.1.3 Depressive symptoms
Whereas pain is the most common physical reason to seek medical help, the predominant
psychological symptom is depressive symptoms (Kroenke et al., 2009). Therefore, the high
comorbidity of depressive symptoms and pain is understandable (Knaster, 2012; Kroenke, 2009).
The relationship between depression and pain is known to be bidirectional (Edwards, 2016). It has
been proposed that coexistence of pain and depression is in part due to underlying inflammatory
mechanisms (Walker et al., 2013).  Inflammation is a known nominator behind both, activating
several pathways that can trigger either transition of acute to persistent pain or the development
of depression (Walker et al., 2013). Negative affect is one important part of depressive
symptomatology and known to modulate pain perception (Janssen, 2002). However, it also has been
suggested that negative affect influences the reporting of pain (Aronson et al., 2006).
In a recent meta-analysis of pain perception in people with depression, a conclusive association
between pain tolerance or threshold and depression was not found (Thompson et al., 2016). While
an association between experimental pain and depression exists, it is complex. Depression seems
to differently affect different modalities of pain, either increasing (ischemic stimulation) or
decreasing (other modalities) the pain response (Thompson et al., 2016).
The influence of depression on pain may be indirect. Depressed individuals feel more disabled by
their symptoms, and results of pain rehabilitation are often poorer (Edwards, 2016; Leeuw, 2007;
Linton, 2011). Unfavorable health behavior, such as smoking and physical inactivity, as well as high
BMI  are  also  known  to  have  an  association  with  both  depression  and  pain  (Igna  et  al.,  2008).
Depression is often considered to be an outcome of persistent pain (Knaster, 2012). In a Finnish
study done with tertiary pain clinic patients, the comorbidity of persistent pain and depression was
37%, and depression was found to be more a result of a chronic pain condition than to precede the
pain (Knaster et al., 2012). Symptoms of depression and especially major depressive disorder (MDD)
may  also  add  to  the  risk  of  pain  and  postsurgical  complications  e.g.  postoperative  infections
(Doering et al., 2007). Depressive symptoms, especially severe cases, have been shown to precede
more severe postsurgical pain in several studies (Hinrichs-Rocker et al., 2009; Sobol-Kwapinska et
al., 2016), also in a breast cancer cohort (Miaskowski et al., 2012). A study with Finnish cancer
patients  found that  depression was associated also with breast  cancer progression (Lehto et  al.,
  Pain Sensitivity and Factors associated with the Pain Experience after Breast Cancer Treatments |   37   
2006). The psychobiological mechanisms affecting cancer progression are suggested to be related
to psychological stress (Kiecolt-Glaser & Glaser, 1999).
When depression has been studied in pain or in the context of breast cancer, usually the symptoms
of depression have been evaluated. Few studies have used a diagnostic interview to clarify the
severity of clinical depression or the presence of MDD. The three most frequently used scales are
the Hospital Anxiety and Depression Scale (HADS) (Snaith & Zigmond, 1986), the Beck Depression
Inventory (BDI) (Beck et al., 1961), and the Center for Epidemiological Studies Depression Scale (CES-
D) (Radloff, 1977). HADS is found to provide the lowest scores relative to CES-D and BDI (Maass et
al., 2015). This may reflect the role of physiological questions in the latter two questionnaires, which
have questions overlapping with somatic symptoms caused by the disease and its treatment and
may overestimate the symptoms of depression. PHQ-9 (Spitzer et al., 1999) is a depression
questionnaire increasingly used to assess depression in particular in somatic conditions (Fisher et
al., 2017). Although it has been shown that somatic questions affect the responses in the widely
used BDI (Knaster et al., 2016; Morley et al., 2002), this is not necessarily a sign of overestimation
of the severity of depression. In a Finnish study, the results of the diagnostic interview of chronic
pain patients were comparable with the level of depression evaluated with BDI (Knaster et al., 2016).
There is no clear consensus as to which scales should be used and how to manage the role of somatic
symptom questions in the depression scales (Knaster et al., 2016; Maass et al., 2015).
2.4.1.4. Anger regulation
Compared with depression and anxiety, the study of anger regulation is a relatively new area in pain
research. Even though the relationship between pain and anger inhibition has been introduced at
least in theory in early psychoanalytical literature (Freud, 1917; Engel, 1959), the broader meaning
of regulation strategy is newer. Anger can be seen as different from aggression. Anger is more of a
cognitive and emotional reaction to a provoking situation, whereas aggression also includes the aim
to cause harm and damage to other people or objects (Spielberger, 1999). Anger regulation, as
emotion regulation in general, may be an automatic or controlled process (Spielberger, 1999; Gross,
1998). Regulation may be seen as a part of cognitive and behavioral efforts to cope with external or
internal demands on a person and a way to maintain personal resources (Lazarus & Folkman, 1984).
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The chosen strategies may have an effect on the way a person adapts to life after cancer and the
extent of interference attributed to pain (Julkunen et al., 2009; Lehto et al., 2005; Bruehl et al., 2002;
Bruehl et al., 2008; Ducro et al., 1995).
Two strategies of emotional regulation in general have been studied in more detail: emotional
expression and suppression (Gross, 1998). Also the study between anger regulation and pain has
focused on these strategies, anger expression and anger inhibition. Anger regulation strategies, how
an individual usually behaves when feeling angry, have been thought to be quite stable traits (Linden
et al., 2003; Spielberger, 1999). Anger inhibition reflects a disposition to suppress angry feelings,
e.g. “I´m criticizing others in my mind”, whereas anger expression reflects a person’s way to express
angry feelings outwards,  e.g.   “I  may slam doors when angry” (Spielberger,  1999).  The theory of
anger regulation has been criticized as being an overly simplistic way to describe the variety of ways
individuals may express or inhibit their anger (Linden, 2003). Also, it does not take into account the
situational variety of anger regulation strategies (Linden, 2003; Burns, 2008). Individuals may react
to one anger-arousing situation by shouting or losing their temper, but in another by keeping angry
thoughts inside.  Long follow-up studies are not available regarding how this behavior evolves with
e.g. age. In addition, whether this behavior changes during dramatic life events, such as severe
disease, is unknown.
Like mood factors, also anger regulation is thought to influence pain experience through
physiological, affective, and cognitive mechanisms (Bruehl et al., 2003; Bruehl et al., 2008a; 2008 b;
Bruehl et al., 2011; Burns et al., 2008; Greenwood et al., 2003; Trost et al., 2012). Anger regulation
processes have been suggested to be potentially meaningful contributors to mental and also
physical health, e.g. to the development of coronary disease and blood pressure (Burns et al., 2008;
Gross, 1998; Igna et al., 2009; Julkunen et al., 2009; Krantz et al., 2006; Stanton et al., 2000), and
thus, to the quality of life (Julkunen et al., 2009; Lehto et al., 2005).  Not only the arousal of anger
or aggression per se, but the manner in which anger is regulated is thought to be relevant to the
pain experience (Bruehl et al., 2006; Burns et al., 2008).
The relation of anger and pain is not straightforward, and contradictory findings in both acute and
chronic pain experience have been published (Bruehl et al., 2009; Bruehl et al., 2012; Materazzo et
al., 2000; Nisenzon et al., 2014; Sayar et al., 2004). Bruehl et al. (2003) found higher anger expression
to be linked to CRPS (Complex Regional  Pain Syndrome) -related pain,  but  not to other types of
upper extremity pain. In one study, anger inhibition was related to pain intensity in headache
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patients (Nicholson et al., 2003), and in other study neither inhibition nor expression of anger was
relevant to pain intensity (Materazzo, 2000). However, especially anger expression has been
reported to be associated with higher or more unpleasant pain experience (Bruehl et al., 2002;
Bruehl et al., 2008). Anger inhibition, by contrast, may have more of a mediating role in the pain
experience through negative affect, depressive symptoms, and anxiety (Burns et al., 2008; Duckro
et al.,  1995;  Nisenzon et  al.,  2014;  Okifuji  et  al.,  1999).  Furthermore,  it  has been suggested that
anger inhibition and expression are probably mediated through different pathways, and therefore,
also differently overlap with pain, depression, and anxiety with respect to pain (Bruehl et al., 2003).
The explanations regarding the effects of anger expression on pain have mostly been physiological,
e.g.  increased  muscle  reactivity  (Burns,  1997)  or  activation  of  the  sympathetic  nervous  system
(Bruehl et al., 2003). Also, anger expression has an impact on the immune system (Kiecolt-Glaser et
al., 2002), and an influence on genetic polymorphisms has been suggested (Bruehl et al., 2008b).
Bruehl et al. (2008a; 2008b) have also proposed that individuals with a higher tendency to express
anger have a deficient endogenous opioid system. This mechanistic approach to evaluate anger
regulation as a cause of biological variables is very different from the contextual explanation where
the relationship between anger regulation and pain is perceived as more interactive. From a
contextual perspective, anger regulation affects how a person copes with pain. As an example of
the behavioral perspective, Duckro et al. (1995) suggest that anger mediated by depression
influences pain-related disability, but not particularly the intensity of pain.
Some evidence has emerged that the role of anger regulation in pain experience is different
between the genders. In a study done with chronic pain patients, a higher tendency to express anger
was associated with worse rehabilitation outcomes in men, but not in women (Burns et al., 1998).
Also opioid analgesia was weaker in women with high anger expression in an experimental pain
situation, but this was not shown in men (Bruehl et al., 2007). One study evaluating the role of anger
expression in postsurgical acute pain found a positive correlational association in men (Bruehl et al.,
2006b).  No studies have evaluated the effect of anger regulation on the intensity of acute or
persistent pain in a breast cancer patient cohort. Most studies evaluating the role of anger
regulation in pain experience have used the Spielberger State-Trait Anger Expression Inventory
(STAXI). Consequently, Burns (2008) stated that the relationship between anger regulation and pain
reflects more the quality of that specific scale rather than reflecting the whole truth about the
construct of anger regulation.
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2.5. PSYCHOLOGICAL FACTORS AND BREAST CANCER
Symptoms of depression and anxiety are well-recognized and natural reactions to the cancer
diagnosis. Like breast cancer and pain, also symptoms of depression and anxiety are more common
in females (Li & Graham, 2017; Markkula N. et al., 2016). A recent Finnish study (Kokkonen et al.,
2017) found that the prevalence of depression in breast cancer patients (37%) was significantly
higher than in the general population in Finland (from 4.9% to 9.3%) (Pirkola et al., 2005). A recent
large review (Maass et al., 2015) evaluated the prevalence of depression and anxiety in a long
follow-up among breast cancer survivors and reported 39.9% (range 9.4-66.1%) of women to have
depressive symptoms and 27.2% (range 17.9-33.3%) to have anxiety. They concluded that the
symptoms of depression usually increase at the first year after diagnosis, whereas anxiety remains
stable.  Symptoms  of  depression  were  also  more  common  in  breast  cancer  patients  relative  to
healthy controls in an eight-year follow-up, whereas presence of anxiety did not differ between
these groups in the follow-up (Maass et al., 2015). Both anxiety and depressive symptoms are at the
highest during the first year of diagnosis (Begovic-Juhant et al., 2012; Zainal et al., 2013).
2.6. POSTOPERATIVE PAIN
2.6.1. ACUTE PAIN
Nociception alone is not sufficient to produce pain experience. However, nociception is essential for
an individual’s survival since it is required for reflexive and protective autonomic responses. Acute
pain is a warning signal for an individual that something is wrong in the body. The nociceptive
reaction to pain is followed by a more conscious interpretation of pain. This has been shown also in
functional brain imaging studies where the conscious experience of pain has emerged when neural
input has been integrated to different cortical regions (Lee & Tracey, 2013). Postsurgical acute pain
is physiologically different from other pain conditions, e.g. herpes zoster pain or fibromyalgia
(Brennan, 2011), but also different psychologically. The onset of postsurgical pain is known and
psychological factors, e.g. anxiety, surgical worry, and pain anticipation, are inevitably a part of the
acute pain experience. Normally, surgically induced pain at rest resolves within a week, but the pain
in movement often continues longer, even weeks (Brennan, 2011). Postsurgical pain is mostly due
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to tissue injury that sets off a chain of inter-related events, the purpose of which is to fight infection,
limit further damage, and initiate repair (Voscopoulos, 2010). Proinflammatory neurotransmitters
cause both peripheral and central nerve sensitization and heighten pain awareness, aiming to limit
further injury in the affected area. Multiple areas of the pain matrix are known to be activated in
this complex process (Voscopoulos, 2010).
The intensity of severe acute postsurgical pain varies widely between individuals, but also between
surgical procedures. Gerbershagen et al. (2013) listed in their large cohort study comprising 529
different surgical procedures that the highest acute pain intensity procedures were operations
related to obstetrics, orthopedics, and general abdominal surgeries. Surgeries related to breast
cancer were far from the highest acute pain risk procedures (ranks 160 and 166) (Gerbershagen et
al., 2013).
Individual clinical factors associated with higher acute postsurgical pain are known to some extent.
Ip et al. (2009) conducted the first systematic review about factors associated with acute
postoperative pain, including all surgical procedures. They combined factors assessed in different
studies  in  groups,  and  four  main  categories  were  found  to  predict  acute  postsurgical  pain:  age,
psychological factors (especially anxiety), presence of other pain conditions, and surgical type. A
more recent review (Sobol-Kwapinska et al., 2016) analyzing only psychological variables found that
pain catastrophizing, higher expectation of pain, higher depression, and lower optimism were quite
systematically associated with more intense acute postoperative pain.
2.6.1.1. Acute pain after breast cancer surgery
There are a limited number of previous studies assessing factors associated with acute pain after
breast cancer surgery (Table 1) (Bruce et al., 2012; Katz et al., 2005; Rehberg et al., 2017).
Comparison  of  these  studies  is  difficult  since  the  outcome  pain  variables  differ,  as  well  as  the
independent variables. The cut-off for clinically significant pain intensity after surgery has also varied
(Rehberg et al., 2017; Katz et al., 2005). Furthermore, the outcome variable defining acute pain
varies from hours (Rehberg et al., 2017) to days (Katz et al., 2005; Bruce et al., 2012) to up to one
month after surgery (Katz et al., 2005). To minimize a measurement bias related to the moment of
pain rating, it has been suggested that pain trajectories of the acute pain, consisting of both the
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intensity and the direction of the pain path, would give a more precise picture of the nature of acute
pain (Chapman et al., 2011).
Consistent factors predisposing to higher acute pain intensity and more altered sensations after
breast cancer surgery are more invasive surgery type (Rehberg et al., 2017; Bruce et al., 2012; Katz
et al., 2005) and psychological factors, mainly anxiety. Greater preoperative anxiety was a good
predictor of more intense pain both immediately (24 h) (Rehberg et al., 2017) and at two and 30
days after surgery (Katz et al., 2005). Bruce et al. (2012) found a composite resilience variable
consisting of positive attitude and low distress to predict lower pain intensity during the first week
after breast cancer surgery. The role of pain expectancy is rarely assessed in breast cancer studies
(Montgomery et al., 2010), but its predictive value for pain in other surgery types has been found
consistently (Gramke et al., 2009; Logan & Rose, 2005; Pan et al., 2006; Pan et al., 2013; Sommer et
al.,  2010).  As  in  other  surgery  types,  also  in  breast  cancer  surgery  other  existing  pain  problems
before the surgery (Bruce et al., 2012) and younger age (Rehberg et al., 2017; Katz et al., 2005)
predict acute pain. Also, the association of more invasive axillary surgery with more intense acute
pain  is  consistent  (Rehberg  et  al.,  2017;  Bruce  et  al.,  2012).  Extensive  surgery  in  the  axilla  may
potentially damage the sensory intercostobrachial nerves, and if dissection of lymphatics is also
needed, this can cause lymphedema (prevalence is approximately 6-20%) (DiSipio et al., 2013).





























































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































  Pain Sensitivity and Factors associated with the Pain Experience after Breast Cancer Treatments |   45   
2.6.2. TRANSITION FROM ACUTE TO PERSISTENT PAIN
The complex pathophysiological processes behind the transition from acute to persistent
postsurgical pain are not fully understood. It has been suggested that in most cases postsurgical
persistent pain shows signs of neuropathic pain in the acute phase (Chapman & Vierck, 2016; Katz
& Seltzer, 2009).  Tissue damage due to surgery sensitizes sensory endings by peripheral chemicals
and causes inflammation at the surgical site. This causes a burst of afferent nociceptive signaling,
contributing to the development of central sensitization. Infiltration of immune cells and increased
glial cell activation observed in the dorsal horn of the spinal cord following peripheral tissue and
nerve injury causes neuroinflammation, which plays a major role in the induction and also the
maintenance of this central neuronal plasticity (Ji et al., 2014). Woolf and Salter (2000) have
suggested that the remodeling of neuronal synaptic connections in the dorsal horn combined with
pathological neuronal sprouting causes abnormal links between afferent fibers in differing
modalities, e.g. touch and nociception. However, new studies suggest that the line between
inflammatory pain and neuropathic pain is not that clear since inflammatory mediators exacerbate
ectopia in afferent neurons (Bali et al., 2014). The changes in the descending pain modulation
system, and the role of psychological factors in this process, may also have influence on why acute
pain persists after treatments (Chapman & Vierck, 2016; Katz & Seltzer, 2009). A small study done
with women operated on for breast cancer showed that women with persistent postoperative pain
had enhanced temporal summation of mechanical pain and also deficient function in the DNIC test
compared with pain-free patients (Edwards et al., 2013).
2.6.3. PERSISTENT PAIN
Pain experience is far from a linear relation from nociceptive input and conscious experience of pain.
This is especially true when pain transits from acute to persistent. Long-lasting persistent pain does
not have the same purpose as acute pain as a warning signal. The question of vulnerability to
develop persistent pain has been asked already decades ago, and multidimensionality of the process
is certain. Persistent pain due to different causes affects millions of people around the world
(Murray and Lopez, 2013). Also, the burden of persistent postsurgical pain is high measured at both
individual and economic levels (Macrae, 2008). It has been widely accepted that earlier life and pain
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experiences (Afari et al., 2014; Brennstuhl et al., 2014), attributions of pain (Eccleston, 1999),
present context (Carlino et al., 2014), cognitive and emotional variables (Edwards et al., 2016) all
have an effect on the interpretation that forms an experience of pain. These are involved in both
acute and persistent pain, but in persistent pain the role of psychological variables is even more
emphasized.
2.6.3.1. How to study pain persistence
Pain persistence can be studied with a model where the actual time of pain onset can be addressed.
Traditional research settings are studies of postsurgical pain, postherpetic neuralgia, and
posttraumatic pain models (Radresa et al., 2014). Postsurgical pain is perhaps the most studied
model since the cause of pain can be quite precisely controlled. A prospective research setting is
reliable and free from the recall bias known to influence an individual’s retrospective report about
the level of preoperative pain or mood related factors (Van den Bergh & Walentynowicz, 2016). In
a retrospective research setting, there is a tendency to overestimate e.g. adverse symptoms (Van
den Bergh & Walentynowicz, 2016). Pain persistence can be investigated also with twin studies
(Markkula R. et al., 2009 and 2016). Especially the role of genetics in the pain persistence process
can be studied in a situation where the environmental variables are the same between twin pairs,
as mentioned earlier in the text. A cross-sectional cohort design is also common in evaluation of
postoperative pain persistence (Gartner et al., 2009). The prevalence of persistent pain after breast
cancer treatment has been distinctly higher in cohort studies (Bell et al., 2014; Gartner et al., 2009)
than in prospective studies. This may be due to retrospective recall bias.
A very commonly cited theory on pain persistence is the fear-avoidance model (Vlaeyen & Linton,
2000). It is a cognitive-affective model that states that negative emotional and attentional processes
in some individuals focus on the threat value of pain and pain-related stimuli, which may increase
the intensity and perceived disability of pain. It was originally developed to explain the persistence
of low-back pain, but the mechanism may be similar in postoperative pain persistence.
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2.6.4. PERSISTENT POSTOPERATIVE PAIN
Persistent pain after surgical procedures has not been acknowledged in research until about 20
years ago (Crombie et al., 1998). Postoperative pain is considered persistent if it lasts beyond the
average healing time. A more precise and frequently cited definition is by Macrae et al. (2001),
according to which 1) the pain should have developed after a surgical procedure, 2) it should have
lasted at least two months after the operation, 3) other causes for the pain should be excluded (e.g.
chronic infection of ongoing malignancy), and 4) the possibility that the pain is continuing from a
pre-existing problem should be explored and attempted to exclude (Macrae, 2001). More recent
propositions by Werner at al. (2014) to refine the definition are the length (lasted 3-6 months after
surgery) and that the pain should have been developed or increased or have different characteristics
than before the surgery. Nevertheless, these definitions do not take into account the possible
evolving nature of persistent pain. In a large study done with cardiac surgery patients the amount
of reported pain decreased remarkably during a two-year follow-up (Choiniere et al., 2014). A cross-
sectional study with breast cancer surgery patients found that the variation in the courses of pain
between patients was high five to seven years after surgery (Mejdahl et al., 2013).
After breast cancer surgery, the duration of pain may be longer than two months since usually
adjuvant treatments are not yet over. Persistent pain risk procedures, such as thoracic surgery,
breast surgery, and groin hernia repair, have been shown to have a high prevalence of probable or
definite neuropathic pain (Duale et al., 2014; Finnerup et al., 2016; Haroutiunian et al., 2013). As
presented in Table 2, commonly identified risk factors for pain persistence are the same regardless
of the surgical type. Pre-existing pain problem, intensity of acute pain, and psychological variables
are the most commonly found factors associated with postoperative persistent pain (Perkins &
Kehlet, 2000; VanDenKerkhof et al., 2013; Ip et al., 2009; Katz et al., 2009). Psychological risk factors
for pain persistence have been compared in a study with knee arthoplasty and breast cancer and
found to be the same: state anxiety and pain magnification related to catastrophizing were
associated with pain regardless of the surgical procedure (Masselin-Dubois et al., 2013).
Psychological variables often associated with persistent postsurgical pain include anxiety,
catastrophizing, depression, psychological vulnerability, and stress (Hinrichs-Rocker et al., 2009;
Khan et al., 2011).
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1247 2 years Preoperative pain↑
Intensity of acute pain↑
Anxiety↑
Montes et al. 2015 Hernia repair
Hysterectomy
Thoracotomy




Duale et al. 2014 Multiple
procedures




















Fletcher et al. 2015 Multiple
procedures
889 1 year Preoperative pain↑
Acute pain intensity↑
Surgery type
Table 2. Factors associated with persistent postoperative pain across surgery types.
2.6.4.1. Persistent pain after breast cancer treatments
Although breast cancer surgery is not the greatest cause of acute postsurgical pain, it is known to
be a high-risk surgery for the development of persistent pain (Cregg et al., 2013; Gerbershagen et
al., 2014). Approximations of the prevalence of persistent pain after breast cancer surgery vary from
14% to 60% (Andersen & Kehlet, 2011; Andersen et al., 2015; Bruce et al., 2012; Miaskowski et al.,
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2014; Wang et al., 2016). Higher prevalences are reported in cross-sectional studies (Andersen,
2011). Based on the current prevalence of breast cancer in Finland (Finnish Cancer Registry), around
700-3000 new patients each year will report persistent pain related to breast cancer treatments.
The reason for pain persistence after breast cancer surgery is multifactorial. In addition to surgery
(Jung et al., 2003), breast cancer treatment usually includes adjuvant therapies that challenge
physical  recovery  after  the  primary  surgery.  Persistent  pain  may  be  encountered  with  both
radiotherapy and certain chemotherapy agents (Jung et al., 2005). The pathological mechanisms
leading to pain persistence after breast cancer treatments are likely multiple, and the pain is
considered  to  have  both  inflammatory  and  neuropathic  components  (Finnerup  et  al.,  2016;
Haroutiunian et al., 2013; Jung et al., 2003; Jung et al., 2005). A large study comparing different
surgery types found that breast cancer patients most commonly had neuropathic features in their
persistent pain compared with other studied procedures (Duale et al., 2014). The pain has often
been classified into intercostobrachial neuralgia, phantom breast pain, neuroma pain, and other
nerve injury pain (Jung et al., 2003).
A recent review (Andersen & Kehlet, 2011) and meta-analysis (Wang et al., 2016) performed to
verify known risk factors for pain persistence following breast cancer surgery concluded that the
comparison of different studies is in part difficult since the definition of the painful area (e.g. breast
only or entire upper body), the cut-off for the intensity of pain regarded as moderate or severe, and
the definition of the duration of pain have wide variation between studies. In addition, most of the
studies have cross-sectional and retrospective designs with causality of findings remaining
unanswered. Furthermore, some studies with prospective design are performed with insufficient
sample sizes (n<100), which enables the reliable use of multivariate statistical methods.
Nevertheless, Wang et al. (2016) concluded in their meta-analysis that younger age, radiotherapy,
more invasive surgery (ALND), preoperative pain, and greater acute pain were the most systematic
and high-quality predictors for persistence of pain at 12-month follow-up.
Previous knowledge on well-powered prospective studies is presented in Table 1. Risk factors
associated with pain after breast cancer surgery are in part the same as for other types of surgery.
The severity of cancer produces variation between surgeries within patients.
50    | REVIEW OF THE LITERATURE
2.6.4.2. Psychological factors and pain persistence after breast cancer treatments
Psychological factors may play a large role in recovery and in the process of pain persistence since
the cause of surgery is malignant and possibly life-threatening. The attribution that a patient assigns
to bodily sensation after a malignant disease is known to be different from a benign disease. A
recent study found that presence of symptoms of depression and anxiety was quite common
(44.5%) at six months after breast cancer surgery (Gold et al., 2016). The relevance of psychological
variables to pain persistence after breast cancer surgery has been controversial between studies,
and most studies have not included preoperative psychological assessment. A cross-sectional study
comparing patients with and without pain at an average of four years from surgery found that
depressive symptoms, anxiety, catastrophizing, and somatization were elevated in women with
persistent pain. Even though the research setting does not allow determination of the causality of
symptoms, this highlights the importance of psychological factors in the pain experience after breast
cancer  surgery  (Schreiber  et  al.,  2013).  Andersen  et  al.  (2015)  evaluated  previously  known
psychological risk factors for pain persistence. Unfortunately, they performed mostly univariate
group comparisons between persistent and non-persistent groups. Patients with pain (NRS ≥4) at
one year after the surgery reported significantly more anxiety, depression, and distress
preoperatively, but surprisingly not catastrophizing. Only preoperative anxiety was included in the
final analyses and found to be an insignificant predictor. The collinearity of the psychological scales
used is a common problem when models are built. Bruce et al. (2014) have taken this into account
in their study by forming a new aggregated variable with factor analysis. They found that this new
variable consisting of high optimism and low psychological distress predicted lower pain after
surgery.
2.7 PREDICTION AND PREVENTION OF PERSISTENT PAIN
2.7.1 PREDICTION
Some risk factors for higher acute and persistent post-treatment pain after breast cancer have been
recognized (Andersen & Kehlet, 2011; Andersen et al., 2015; Bruce et al., 2012; Miaskowski et al.,
2014; Wang et al., 2016; Rehberg et al., 2017; Katz et al., 2005; Bruce et al., 2012). Remaining to be
elucidated, however, are the relative importance of a single risk factor and how to identify patients
at high risk for persistent pain in different interventions. The lack of assessment tools for identifying
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high-risk patients likely arises from the difficulty in constructing reliable and valid tool for the
purpose. The idea of validity and reliability comes from the Classical test theory (Novick, 1966;
Traub, 1997). This is a theory of psychometric testing to better understand the outcomes of
psychological testing and to improve the reliability of psychological tests. Validity of a measurement
refers to the tool measuring the phenomenon that it was designed to measure. Whereas, reliability
refers to the psychometric reliability of a measurement (obtained score on a test is the sum of a
true score and an error score).
2.7.2 PREVENTION
Like most medications, also the proposed analgesic interventions to prevent postsurgical persistent
pain (Kalso et al., 1996; Yarnitsky et al., 2012) may have adverse effects, highlighting the importance
of identifying high-risk patients for these interventions. There are also studies of preventive
psychological interventions for postoperative pain (Ziehm et al., 2017) and even a recent review
focusing solely on breast cancer patients (Johannsen et al., 2013). The effectiveness of these
interventions in preventing pain is controversial (Weinrib et al., 2017; Ziehm et al., 2017; Johannsen
et al., 2013), and the types of interventions used vary widely. Better recognition of the importance
of different factors in persistent pain will allow more targeted psychological interventions to be
developed (Weinrib et al., 2017). For instance, for some individuals the best approach to manage
pain and/or cancer-related anxiety could be the use of relaxation-based interventions, whereas
others will benefit from patient education or supportive therapy (Johannsen et al., 2013).
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3. AIMS OF THE STUDY
The aim was to examine factors associated with pain experience in a female breast cancer cohort.
Specific aims were to identify factors explaining higher experimental pain sensitivity and factors
predicting both higher acute and persistent breast cancer treatment-related pain intensity. Of
particular interest were clinically feasible factors associated with acute and persistent pain
experience.
 Specific aims were as follows:
1. To describe experimental pain sensitivity and to examine clinical factors associated with both
experimental and clinical postoperative acute pain and analgesic use.
2. To identify clinical factors associated with acute pain intensity and its course during the first
postoperative week and to identify clinical factors associated with persistent post-treatment
pain.
3. To identify the role of depressive symptoms, anxiety, and anger regulation in pain experience
at different follow-up time points in this patient cohort.
4. To  develop  an  easy-to-use  clinical  tool  to  identify  women  at  the  highest  risk  for  pain
persistence.
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4. SUBJECTS AND METHODS
4.1 STUDY DESIGN AND PARTICIPANTS
The whole cohort of this prospective study included 1000 patients. These patients were recruited
from the Breast Surgery Unit of Helsinki University Hospital and were operated on between
August 2006 and December 2010. Women who were fluent in the Finnish language, were aged
18-75 years, and had a histologically proven newly diagnosed, unilateral, invasive breast cancer
(T1-4 N0-3 M0) met the inclusion criteria and were invited to participate in the study. Exclusion
criteria were metastasized cancer (other than axillary lymph nodes), clinically significant liver or
kidney  failure,  previous  breast  cancer  surgery  on  the  same  side,  BMI  >35  (from  the  patient
number 100 on), immediate reconstruction at the primary surgery, alcoholism, contraindications
for use of oxycodone, and severe psychiatric disease (e.g. schizophrenia). Prior to enrolment, the
study protocol was disclosed to the subjects. The informed consent was explained carefully to
the patients, and a written informed consent was obtained from all subjects by either a research
nurse or a physician. The recruitment process, exclusion criteria for different sub-studies, and
the number of patients in different sub-studies are presented in a flow-chart (Figure 4).
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Figure 4. Flow-chart of the recruitment and exclusion criteria for different sub-studies.
4.2 DATA COLLECTION
The study protocol and follow-up times for different variables are outlined briefly in Table 3. More
detailed information of the variables included in different sub-studies is provided in the original
publications (Studies I-VI, Methods). The data was collected with paper questionnaires and entered
to the SPSS-files by two research nurses. The data was examined by the researchers to find potential
errors in the data entry. This was done by checking minimum and maximum values and possible odd
numbers.
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4.2.1. DEMOGRAPHIC DATA
Preoperative clinical assessments included data on age, height, and weight, from which the Body
Mass Index (BMI) was calculated. Other data comprised smoking habits (never, yes, stopped), use
of alcohol (no, <6, 6-11, >11, >40 doses per week), drug abuse, and medical and medication history,
e.g. number of previous operations, number of previous cancer, presence of other disease, use of
medication. Presence of chronic pain (e.g. migraine, fibromyalgia) was also asked.
4.2.2.	PAIN-RELATED	ASSESSMENTS
Numerical Rating Scale (NRS)
Most of the pain variables preoperatively and in the follow-up times were assessed using an 11-
point Numerical Rating Scale (NRS). This scale ranges from 0 to 10, where zero means “no pain” and
ten means “the worst possible pain one could imagine”. This is a common method to assess pain in
both clinical and research settings, and it has shown good validity when measuring pain intensity in
various age groups (Gagliese et al., 2005).
Pain in the area of surgery (Studies I-VI)
Preoperatively, the patients were asked to assess pain during the past week in the area of surgery
and to assess the amount of pain they expected to have postoperatively. Immediately after the
surgery, patients were asked about the intensity of pain during motion at five minutes from waking.
Every day during the first postoperative week and at all follow-up points, patients similarly
evaluated the pain intensity in the area of surgery (Table 3). The area of surgery included the breast,
the axilla, and the upper arm (Studies I, II, V, VI) and in Studies III and IV also the lower arm and the
hand  and  fingers.  The  highest  rating  (NRS  0-10)  of  pain  in  any  of  these  areas  was  used  as  an
indication of the intensity of pain.
Experimental pain (Studies I, II, and VI)
Patients were tested 1-3 days prior to the surgery for experimental thermal heat and cold pressure
pain. Thermal heat pain was assessed using the TSA-II NeuroSensory Analyzer. A temperature of
43°C and 48°C was applied, once each, for 5 seconds on the antebrachium contralateral to the side
of surgery. Cold pressure test was measured by immersing the hand contralateral to the side of
surgery in a cold water bath (2-4°C) (JULABO) for as long as the patient can tolerate the test, but for
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a maximum of 90 seconds (Picture 1). Pain intensity and unpleasantness were asked using NRS (0-
10) every 15 seconds and at the end of the test. Time to withdrawal (seconds) and pain intensity
(NRS 0-10) and unpleasantness (NRS 0-10) at withdrawal were measured.
Picture 1. Cold pressure test.
Oxycodone consumption (Studies I,II,VI)
Immediate acute pain was measured with different oxycodone consumption measures. After
surgery, subjects were administered intravenous (IV) oxycodone for pain relief. Patients were
initially titrated with oxycodone by the research nurse until adequate pain relief was obtained (NRS
0-3). The quantity of oxycodone required was recorded and used as a proxy for acute pain intensity
(Studies I, II, and VI). The time until the patient needed a new dose of oxycodone for pain was
recorded. The total amount of oxycodone consumed over 20 hours after the surgery using a Patient-
Controlled Analgesia (PCA) device was recorded. NRS measurements of pain intensity and pain
unpleasantness were recorded (Study I).
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4.2.3. TREATMENT
Anesthesia
An anesthesia protocol was developed in collaboration with the treating anesthesiologists who were
either members of the research team or who were supervised by members of the research team.
Patients were premedicated with diazepam 10 mg and paracetamol (acetaminophen) 1 g. In the
operation theatre, IV infusion of remifentanil (0.2 µg/kg/min) was started. The induction of
anesthesia was achieved with propofol 2-3 mg/kg IV.Trachel intubation was facilitated with
rocuronium and further boluses were given adjusted to clinical needs. The mechanical ventilation
was adjusted to achieve normocapnia with a mixture of oxygen and nitrous oxide. Remifentanil
(short-acting opioid) infusion was used at a rate of 0.05-0.25 µg/kg/min to keep the systolic blood
pressure at the pre-anesthesia level. During closure of the skin, the infusion of remifentanil was
stopped and a 0.07 mg/kg dose of oxycodone was given. A blood specimen for DNA isolation and
banking was drawn during anesthesia to avoid unnecessary injections.
Surgery and oncological treatment
The breast surgeries that the women underwent were either modified radical mastectomy (MRM)
or breast-conserving surgery (BCS). Axillary surgery included either sentinel node biopsy (SNB) or
axillary lymph node dissection (ALND) or both. There was a consistent surgical approach and the
surgeons kept careful records of all surgeries. For statistical analyses (Studies II, IV, V, VI), type of
surgery in the axilla was combined to be categorical SNB alone or ALND with or without SNB. In
Studies I and III, the surgery type was divided into four categories:  BCS with SNB, BCS with axillary
evacuation, mastectomy with SNB, or mastectomy with axillary evacuation.
Oncological adjuvant treatment consisted of radiotherapy, chemotherapy (taxanes, antracyclines,
metotrexat, herceptin), and endocrine therapy (antiestrogens, aromatase inhibitors, LHRH agonists,
or combinations) according to local clinical guidelines (Goldhirsch et al., 2007).
Genetic analyses (Study VI)
The Autopure LS automated DNA purification instrument was used to extract DNA from peripheral
blood (Gentra Systems, Inc., Minneapolis, MN, USA). The SNPs were genotyped using the Sequenom
MassARRAY system and the iPLEX Gold Single Base Extension chemistry (Sequenom, San Diego, CA,
USA) in a multiplex format (Jurinke et al., 2001). To confirm the accuracy of the genotyping results
both duplicate Centre d’Etude du Polymorphisme Humain control and water control samples were
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included in each DNA plate. Phenotypic information was blind when genotyping was performed.
Genotypes OPRM1 rs1799971 (A118G) and COMT rs4680 (Val158Met) were analyzed in Study VI.
4.2.4. PSYCHOLOGICAL QUESTIONNAIRES
Depressive symptoms (Studies I-VI)
The Beck Depression Inventory (BDI) (Beck et al., 1961) was used to measure depressive symptoms.
The BDI is a 21-item self-report questionnaire to assess such depressive symptoms as pessimistic
thoughts, irritability, guilt, and lowered mood. A person responds on a four-point scale from 0 (not
at  all)  to  3  (very  much)  about  how  well  a  statement  describes  her.  A  sum  score  of  all  items  is
calculated to indicate the level of depressive symptoms, higher scores indicating higher depressive
symptoms. Sum scores range from 0 to 63. Cut-off scores for clinical evaluation of the severity of
depressive  symptoms  are  as  follows:  0-9  no  symptoms,  10-18  mild  symptoms,  19-29  moderate
symptoms, and 30-63 severe symptoms (Beck et al., 1961). Cronbach´s α coefficient for BDI in this
cohort was 0.89. BDI has been validated, also in Finnish (Steer et al., 1999; Varjonen et al., 1997),
and it is widely used in Finnish cohorts (Knaster et al., 2016; Kokkonen et al., 2017; Markkula R. et
al., 2016).
Anxiety (Studies I-VI)
State and trait anxiety was measured by using the State-Trait Anxiety Inventory (STAI) (Spielberger
et al., 1983). The STAI is a 40-item scale that evaluates the intensity of both state (20 items) and
trait anxiety (20 items). State anxiety assesses how a person is feeling at a specific time, e.g. “I am
tense”, “I feel safe”, and trait anxiety assesses relatively stable reactions in threatening situations
e.g. “I worry too much over something that really does not matter” and “I´m stable as a person”. A
person responds on a five-point scale ranging from 0 (not at all) to 4 (very much). A sum score of all
items indicates the level of state or trait anxiety. The scores range from 20 to 80, higher scores
indicating a higher level of state or trait anxiety. Cut-off scores for evaluating the severity of anxiety
are 20-40 no-low, 41-60 moderate, and 61-80 severe anxiety (Spielberger et al., 1983). Cronbach´s
α for STAI state and trait were 0.95 and 0.91, respectively. STAI measures symptoms of general
anxiety and is not a pain-specific questionnaire. STAI has also been previously used in breast cancer
cohorts to evaluate the level of anxiety (Tasmuth et al., 1996a; 1996b; Bruce et al., 2012 and 2014;
Rehberg et al., 2017; Katz et al., 2005; Miaskowski et al., 2012).
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Anger regulation (Study VI)
The Anger Expression Inventory, revised version (STAXI-2) was used to evaluate the way that
individuals typically regulate their anger. Anger regulation is often divided into two strategies: anger
expression (anger-out, angry feelings are expressed in physically or verbally aggressive behavior)
and anger inhibition (anger-in, angry feelings are suppressed, i.e. not expressed verbally or
physically) (Spielberger, 1999). Questions assessing anger-out include statements like: “I lose my
temper” and “I may slam doors and throw things” and for assessing anger-in: “I try not to show my
anger” and “I´m criticizing others in my mind”. STAXI-2 is a commonly used scale to assess anger
regulation in somatic diseases, also in pain studies (Burns et al., 2008; Duckro et al., 1995; Estlander
et al., 2008; Julkunen et al., 2009; Lehto et al., 2005). Both sub-scales comprise 8 items and a person
responds on a four-point scale ranging from 0 (not at all) to 3 (completely true) about how well each
claim describes typical behavior when angry. A sum score is calculated for both subscales and it can
vary between 0 and 24, with a higher number indicating a greater tendency to either inhibit or
express anger. Cronbach´s α was 0.77 for anger-in and 0.74 for anger-out.
4.3. STATISTICAL ANALYSES
The data were analyzed using SPSS software (versions 19.0.0.1 and 22.0 for Windows, SPSS Inc.,
Chicago, IL, USA), the R statistical package (versions 2.14.2 and 3.2.2), pROC package (version 1.8)
(Robin et al., 2011), and Python 2.7.11 module Statsmodels (version 0.6.1). Studies I, II, and IV-VI
were performed using traditional statistical methods. In Study III, multivariate analyses were
performed using the Bayesian method (Carlin & Louis, 1996). Tests of normality were conducted
using the Kolmogorov-Smirnov test and by estimating skewness and kurtosis. Descriptive data were
presented as means (standard deviations, SDs), medians (ranges), and numbers (percentage) when
appropriate.
Comparisons between different study groups were performed using either parametric or non-
parametric tests depending on variable distributions. Student’s t-test and Pearson`s correlational
coefficient for normally distributed data and Mann-Whitney U-test, Kruskall-Wallis, and Spearman´s
correlational coefficient for non-parametric data. Chi-square test was used for analyzing differences
between categorical variables. The p-value correction was performed by using the Bonferroni-
correction. To estimate the reliability (internal consistency) of the psychological questionnaires (BDI,
STAI and STAXI-2) Cronbach´s α coefficients were calculated. There were singular missing items in
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psychological questionnaires that were imputed by replacing the missing item with the mean value
of the other items the person had answered. If a patient had ≥20% missing items, the questionnaire
was removed from the analyses. The amount of missing items in the questionnaires was low, usually
there was only one missing item per person and approximately 1-3% of the patients had missing
values per questionnaire. Singular missing values were imputed by the mean value of the answered
items. This was done to be able to include as many participants as possible to the final data. The
number of imputed items was small and therefore not likely to add the risk of the Type I or II error.
Type I error occurs when the null hypothesis is true but falsely rejected, and the Type II error when
the false null hypothesis is not rejected. The outcome variable “The amount of oxycodone needed
for the first state of satisfactory pain relief” (Study VI) underwent a logarithm transformation to
achieve more normal distribution.
To describe acute pain during the first postoperative week (Study II), the pain trajectories were
formed by fitting a regression line across the pain measures of the seven postoperative days using
an ordinary least-squares fit. The trajectories include two features, the intensity of pain on the
hypothetical day zero assessment point (the intercept) and the change in pain intensity with time
(the slope). Figure 5 gives an example with five different patients of how the linear line was fitted
through the exact values during the first week, also showing how different slopes were formed.
Figure 5. Trajectories of five individuals’ pain resolution over the first postoperative week.
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Three groups according to the direction of the slope were formed. Individual slope values with 50%
confidence intervals (CI) were calculated and slopes with CI crossing value zero were defined as flat
slopes, whereas entirely positive CIs were considered increasing slopes and entirely negative CI were
defined as decreasing slopes.
In Studies I, II, and IV-VI, multivariate analysis was performed using traditional statistical methods:
linear regression (I, II, VI) ordinal logistic regression (IV), and stepwise binary logistic regression (V).
Based on the results of the binary regression analyses (Study V), prediction models for pain
persistence were developed at different time points (preoperative, intraoperative, 1st postoperative
day, and 7th postoperative day models) and validated in two separate breast cancer patient cohorts.
The performance of the prediction models was assessed by the area under the receiver-operating
characteristic curves (AUC-ROC). The sensitivity and specificity rates were calculated for each of the
models. These are statistical measures evaluating the goodness of the classification test. Sensitivity
refers to the proportion of positive findings that are correctly identified as positive (a patient with
pain correctly identified as having pain). Specificity refers to the proportion of negative findings that
are correctly identified as negative (a patient with no pain correctly identified as having no pain). In
Study III, the Bayesian method was used to determine those variables that best explained clinically
significant  pain  at  six  months  (Carlin  &  Louis,  1996;  Pelkonen  et  al.,  2012).  First,  preoperatively
collected data and surgery- and adjuvant treatment-related data were analyzed separately. Then
these were combined. The sum variables were produced through logarithmic transformation of the
Bayesian values (Kurki and Kataja, 1996). Finally, a multifactorial risk index was constructed and a
tool comprising six factors was chosen.
General linear model (GLM) repeated-measures analysis was used to assess the associations
between anger regulation and mood in the three-year follow-up (Study VI).
4.4. ETHICAL ASPECTS
The research protocol was approved by the Coordinating Ethics Committee of the Helsinki University
Hospital (136/E0/2006) and the Ethics Committee of the Department of Surgery (Dnro 148/E6/05)
of the Hospital District of Helsinki and Uusimaa (HUS). All subjects were fully informed of study
procedures, potential risks, and their right to withdraw from the study at any time. All reasonable
precautions were taken (including coding of specimens and clinical data files) to prevent loss of
confidentiality. Genetic data were not revealed to the patients. If a patient reported high intensity
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of pain, she was contacted by the research nurse who then consulted the research team. When
needed, the patient was referred to the pain clinic for management.
5. RESULTS
5.1. CHARACTERISTICS OF PATIENTS
The mean age of the whole cohort of 1000 women was 57 years (SD 9.3), ranging from 28 to 75
years.  The  average  BMI  was  25.4  (SD  4.3),  ranging  from  16  to  42.8.  Almost  one-fourth  of  the
patients, 24% (n=240), reported a chronic pain condition (e.g. musculoskeletal pain, migraine,
fibromyalgia) preoperatively. The majority of the women had never smoked regularly (59.1%),
22.8% had stopped smoking, and 16.7% were still smoking every day and 1.4% periodically. No
alcohol use was reported by 17.4%, less than 6 doses per week by 64.4%, 6-11 doses per week by
13.2%, and >11 doses per week by 5% of the women. The type of breast surgery was resection in
62.5% (n=625) and mastectomy in 22.7% (n=375). Of the patients, 56% (n=560) had only sentinel
node biopsy in the axilla, whereas 44% had axillary clearance. At 6 months after the primary surgery,
there were 48 women who had had a second surgery, and axillary clearance was performed on a
total of 486 patients (48.6%). At 5 years after surgery, the survival rate of the patients was 96.2%
(new  data).  At  12,  24,  and  36  months  after  the  surgery  there  was  no  statistically  significant
difference between the responders and non-responders regarding the baseline depressive
symptoms, anxiety or anger regulation variables. However, the non-responders were more often
smokers (p=0.002, p=0.007, p=0.016, respectively), and had higher numbers of metastatic lymph
nodes (p=0.011, p=0.001, p=0.005, respectively). Non-responders at 12 and 36 months were
younger at baseline than responders (p=0.026 and p=0.041). These differences are unlikely to cause
significant bias, as the response rate was so high.
Three groups according to the direction of the slope were formed. Individual slope values with 50%
confidence intervals (CI) were calculated and slopes with CI crossing value zero were defined as flat
slopes, whereas entirely positive CIs were considered increasing slopes and entirely negative CI were
defined as decreasing slopes.
In Studies I, II, and IV-VI, multivariate analysis was performed using traditional statistical methods:
linear regression (I, II, VI) ordinal logistic regression (IV), and stepwise binary logistic regression (V).
Based on the results of the binary regression analyses (Study V), prediction models for pain
persistence were developed at different time points (preoperative, intraoperative, 1st postoperative
day, and 7th postoperative day models) and validated in two separate breast cancer patient cohorts.
The performance of the prediction models was assessed by the area under the receiver-operating
characteristic curves (AUC-ROC). The sensitivity and specificity rates were calculated for each of the
models. These are statistical measures evaluating the goodness of the classification test. Sensitivity
refers to the proportion of positive findings that are correctly identified as positive (a patient with
pain correctly identified as having pain). Specificity refers to the proportion of negative findings that
are correctly identified as negative (a patient with no pain correctly identified as having no pain). In
Study III, the Bayesian method was used to determine those variables that best explained clinically
significant  pain  at  six  months  (Carlin  &  Louis,  1996;  Pelkonen  et  al.,  2012).  First,  preoperatively
collected data and surgery- and adjuvant treatment-related data were analyzed separately. Then
these were combined. The sum variables were produced through logarithmic transformation of the
Bayesian values (Kurki and Kataja, 1996). Finally, a multifactorial risk index was constructed and a
tool comprising six factors was chosen.
General linear model (GLM) repeated-measures analysis was used to assess the associations
between anger regulation and mood in the three-year follow-up (Study VI).
4.4. ETHICAL ASPECTS
The research protocol was approved by the Coordinating Ethics Committee of the Helsinki University
Hospital (136/E0/2006) and the Ethics Committee of the Department of Surgery (Dnro 148/E6/05)
of the Hospital District of Helsinki and Uusimaa (HUS). All subjects were fully informed of study
procedures, potential risks, and their right to withdraw from the study at any time. All reasonable
precautions were taken (including coding of specimens and clinical data files) to prevent loss of
confidentiality. Genetic data were not revealed to the patients. If a patient reported high intensity
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of pain, she was contacted by the research nurse who then consulted the research team. When
needed, the patient was referred to the pain clinic for management.
5. RESULTS
5.1. CHARACTERISTICS OF PATIENTS
The mean age of the whole cohort of 1000 women was 57 years (SD 9.3), ranging from 28 to 75
years.  The  average  BMI  was  25.4  (SD  4.3),  ranging  from  16  to  42.8.  Almost  one-fourth  of  the
patients, 24% (n=240), reported a chronic pain condition (e.g. musculoskeletal pain, migraine,
fibromyalgia) preoperatively. The majority of the women had never smoked regularly (59.1%),
22.8% had stopped smoking, and 16.7% were still smoking every day and 1.4% periodically. No
alcohol use was reported by 17.4%, less than 6 doses per week by 64.4%, 6-11 doses per week by
13.2%, and >11 doses per week by 5% of the women. The type of breast surgery was resection in
62.5% (n=625) and mastectomy in 22.7% (n=375). Of the patients, 56% (n=560) had only sentinel
node biopsy in the axilla, whereas 44% had axillary clearance. At 6 months after the primary surgery,
there were 48 women who had had a second surgery, and axillary clearance was performed on a
total of 486 patients (48.6%). At 5 years after surgery, the survival rate of the patients was 96.2%
(new  data).  At  12,  24,  and  36  months  after  the  surgery  there  was  no  statistically  significant
difference between the responders and non-responders regarding the baseline depressive
symptoms, anxiety or anger regulation variables. However, the non-responders were more often
smokers (p=0.002, p=0.007, p=0.016, respectively), and had higher numbers of metastatic lymph
nodes (p=0.011, p=0.001, p=0.005, respectively). Non-responders at 12 and 36 months were
younger at baseline than responders (p=0.026 and p=0.041). These differences are unlikely to cause
significant bias, as the response rate was so high.
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5.2 PAIN
Reports of pain in the area of surgery at different time points are presented in Table 4.
Preoperative 6 months 12 months 24 months 36 months
n % n % n % n % n %
NRS  0-3 928 92.8 756 87.4 744 86.5 691 89.7 635 89.6
NRS 4-10 72 7.2 109 12.6 116 13.5 79 10.3 74 10.4
Total 1000 865 860 770 709
Table 4. Number of patients reporting no to low pain (NRS 0-3) or moderate to severe pain (NRS 4-
10) in the area of surgery preoperatively and after the surgery.
5.2.1. ACUTE PAIN
5.2.1.1. Experimental pain (Studies I, II, VI)
The patients varied widely in the sensitivity to both experimental heat and cold pain, and the
tolerance of cold pain. There was a correlation between heat and cold experimental pain (cold
withdrawal time and heat pain intensity, r=-0.32); the shorter the time to withdrawal in the cold
water test, the higher the reported heat pain intensity. In the cold pressure test, there were 117
patients (13%) who kept their hand in the cold water for less than 15 s, and approximately one-
quarter (24%) of the patients tolerated the cold water for the maximum of 90 s. The average time
tolerated was 46.4 ± 29.5 s. Experimental pain sensitivity was only weakly correlated with the acute
pain measures: total oxycodone consumption (experimental heat pain 48°C, r=0.10; and cold
pressure test maximum time tolerated, r=-0.11) and pain during motion at 5 min from waking (cold
pressure test maximum time tolerated, r=-0.08; and heat pain 48°C, r=0.13) (Study I). The patients
who reported a higher expectation of postoperative pain (NRS 7-10 vs. NRS 0-3) were more sensitive
to heat pain at 48°C (p<0.001) and kept their hand in the cold bath for a shorter time (p=0.001)
(Study II).
Of  the  studied  variables  (Study  I),  state  anxiety  had  the  strongest  effect  on  experimental  pain
sensitivity (heat pain 48°C β=0.02, p=0.012; cold pressure test maximum time tolerated β=-0.43,
p=<0.001, and cold pain intensity (15 s) β=0.032, p=0.002). Preoperative chronic pain condition was
associated with shorter toleration of cold pain (β=-6.68, p=0.034), higher heat 48°C pain (β=0.69,
p=0.001), and higher cold pain (15s sensitivity (β=0.62, p=0.048). Number of previous operations
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was also associated with the intensity of experimental pain (heat pain 48°C β=0.137, p=0.018).
Women reporting higher anger inhibition (anger-in) reported higher heat pain sensitivity compared
with their low anger-in peers (mean 3.16 vs. 3.80, t=-2.17, p=.031, d= -0.27). This univariate
association  was  not  seen  in  the  linear  regression  analyses  after  controlling  for  anxiety  and
depressive symptoms (Study VI).
As new data for this thesis (previously unpublished results), correlations between experimental pain
variables and acute pain trajectories were calculated (Table 5). There was a significant, but weak
correlation between the first week pain intensity (the intercept) and the studied experimental
measures. As new data, experimental pain sensitivity was compared between persistent pain groups
at one year after the surgery (NRS 0-3 vs. NRS 4-10). Patients in a pain group (NRS 4-10) reported
significantly more intense heat pain (mean 3.4 vs. 4.1, t=-3.03, p=0.003, d=-0.21). No differences in
cold pain tolerance or pain at 15 s were found.
Heat pain 48c
(NRS 0-10)
Cold pressure pain intensity at
15 s (NRS 0-10)
Cold pressure total time
tolerated (s)
First week acute pain
trajectory slope
NS NS NS









** Correlation is significant at the 0.01 level * Correlation is significant at the 0.05 level (2-tailed). Available data from the
study II were included in this analysis.
Table 5. Correlations between the first week pain trajectories and experimental pain sensitivity.
5.2.1.2. Clinical perioperative pain (Studies I, II, VI)
The type of surgery in the axilla was relevant to the intensity of immediate pain measures. Patients
who underwent more invasive axillary clearance surgery needed significantly more oxycodone
during  20  h  after  surgery  than  patients  with  sentinel  node  biopsy  (p=<0.001).  The  total  use  of
oxycodone at 20 h (mg/kg) was associated with younger age (β=-0.005, p<0.001), lower BMI (β=-
0.005, p<0.001), previous chronic pain condition (β=0.048, p=0.001), presence of preoperative pain
in the breast to be operated (β=0.039, p=0.004), and higher state anxiety (β=0.002, p=0.003). These
variables explained approximately 16% of the total variance (r²=0.158) in oxycodone consumption.
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Younger patients needed more oxycodone to achieve satisfactory pain relief for the first time after
the surgery (β=0.128, p<0.001) and reported more pain during motion before the 1st dose of
oxycodone (β=-0.028, p<0.001). Women with elevated anger expression (anger-out) needed
significantly more oxycodone to achieve satisfactory pain relief for the first time after surgery (log-
transformed mean -1.62 vs. -1.49, t=-3.02, p=.003, d= -0.33) than women reporting low levels of
anger-out. This univariate finding was not significant in the hierarchical regression analyses after
controlling for age (Study VI).
5.2.1.3. Pain during the first postoperative week (Study II)
More than five out of six patients (84.4%) expected postoperative pain to be moderate to severe
(Study II). Figure 6 shows the proportions of patients with different expectations of postoperative
pain (low pain 0-3, moderate pain 4-6, and severe pain 7-10) that actually had pain ≥4 preoperatively
or during the first postoperative week.
Figure 6. Distributions of different pain expectation groups of women reporting pain NRS ≥ 4
preoperatively and during the first postoperative week.
Figure 7 displays the courses and intensities of the first postoperative week in the entire cohort of
1000 women. There is a negative correlation between the intercepts and the slopes; the greater the
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initial pain, the faster it resolves during the first post-operative week. Three groups were identified
based on the direction of the slope. The proportion of patients whose pain remained quite stable
over the first week (flat slope) was 31.1%. In 19% of patients, pain increased over the week (positive
slope), and in 49.7% pain decreased over the week (negative slope).
Figure 7. Association between intensity (the intercept) and resolution (the slope) of pain during the
first postoperative week.
The initial pain intensity and its resolution during the first postoperative week was modeled by using
the pain trajectories. The factors that explained one-fourth (r²=0.25) of the initial intensity of the
pain during the first week (the intercept) were the type of axillary surgery (SNB β=-0.39, p=0.03),
preoperative pain in the area of surgery (β=0.17, p=0.01), psychological distress (anxiety and
depressive symptoms) (β=0.24, p=0.01), expectation of postoperative pain (β=0.16, p<0.001), and
the amount of oxycodone needed for the first state of adequate analgesia (β=3.88, p<0.001). A more
negative slope (faster pain resolution) was explained mostly by those factors that explained high
initial pain intensity: expectation of pain (β=-0.02, p=0.02), the amount of oxycodone needed for
the first state of adequate analgesia (β=0.44, p=0.01), and high BMI (β=-0.01, p<0.001). The variance
of the slope was explained by these factors only modestly (r²=0.04).
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5.2.2.	PERSISTENT	PAIN	(Studies	II-VI)
5.2.2.1. Persistent pain at six months
In a subgroup of the whole cohort (first 489 patients), at six months after surgery 87.1% of the
patients reported no or low pain intensity (NRS 0-3), and clinically significant pain (NRS 4-10) was
reported by 12.9% (n=63) of the patients (Study III). This analysis also included the worst pain in the
lower arm, joints, and fingers. Table 4 shows the percentages of different pain intensities in the area
of surgery (the breast, the axilla and the upper arm) at all time points of the study with all available
data. In order to create a clinically useful prediction tool, we chose six factors that best explained
persistent pain at six months. These factors were chronic preoperative pain (OR 2.99; CI 1.76-5.08;
p<0.001), number of previous operations ≥4 (OR 2.91; CI 1.62-5.25; p<0.001), preoperative pain in
the area of surgery ≥4 (OR 2.90; CI 1.32-6.39; p=<0.01), BMI ≥31 (OR 3.38; CI 1.83-6.24; p<0.001),
previous smoking (OR 2.41; CI 1.41-4-17; p<0.01), and age ≥70 years (OR 2.01; CI 0.84-4.78; p=NS).
Sum score for estimation of the risk of developing moderate or severe persistent pain in the
operated area was created by weighting the factors in the model based on their relative contribution
to the risk. The chosen cut-off limit (20) identifies 81% (sensitivity) of those who will develop
persistent pain, but 56% (specificity) will be false-positive assumptions.
5.2.2.2. Persistent pain at one year
As the data were re-analyzed for this dissertation summary, an unfortunate error in the data analysis
of Study IV was found. Instead of the preoperatively acquired scores for psychological factors,
depressive symptoms (BDI), and State and Trait Anxiety Questionnaires (STAI), the questionnaire
scores from the 12-month follow-up were used. The erratum was made to the journal (JAMA) and
the corrected values of all variables are presented here. Risk factors for persistent pain at 12 months
after surgery were assessed (Study IV) with all available data (n=860). Table 4 shows the distribution
of reported clinically significant pain. Factors that were significantly associated with higher pain
intensity as an ordinal variable (NRS 0-10) were mainly either treatment-related variables: type of
axillary surgery (clearance) (OR 0.38 CI 0.28-0.52; p<0.001) received chemo- (OR 1.48 CI 1.10-2.01;
p=0.01) and radiotherapy (OR 0.52 CI 0.39-0.69; p<0.001), or pain-related variables: chronic
preoperative pain (OR 0.67 CI 0.50-0.89; p=0.006) and preoperative pain in the area of surgery (OR
1.47 CI 1.35-1.60; p<0.001). From psychological variables, higher trait anxiety was associated with
higher pain intensity (OR 1.02 CI 1.01-1.04). In the reanalysis of the data, the only change was that
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depressive symptoms was replaced by trait anxiety. Depressive symptoms at 12 months after
surgery were associated with higher pain experience at that time (12 months) (OR 1.04 CI 1.00- 1.08;
p=0.003).
In the second prediction tool study (Study V), all available data at the one-year follow-up were
analyzed and the outcome variable was pain at 12 months categorized as no or low pain (NRS 0-3)
or moderate to severe pain (NRS 4-10). Four different stepwise logistic regression analyses were
conducted with factors collected at different time-points (pre- and perioperatively, first and seventh
postoperative days). From the preoperative factors, preoperative pain in the area of surgery was
associated with pain intensity at 12 months (OR 1.39 CI 1.24-1.56; p<0.001). When perioperative
factors were added to the model, also BMI ≥31 (OR 1.86 CI 1.06-3.24; p=0.030), and axillary
clearance (OR 2.19 CI 1.44-3.34; p=0.002) were significant predictors of pain intensity. The intensity
of acute postoperative pain on the first (OR 1.11 CI 1.02-1.21; p=0.017) and seventh postoperative
days (OR 1.17 CI 1.05-1.29; p=0.003) was also associated with higher pain intensity and added to
subsequent models. All of the factors predicting persistent pain in the previous models remained in
the subsequent model, except the 1st day acute pain intensity, which was replaced by the intensity
of pain on the 7th day in the last model. Odd ratios remained quite stable throughout the models.
Based on the proportion of patients having persistent pain, the risk estimates in the different
datasets on the seventh postoperative day were calculated for three different levels (<20% low risk,
20-30% moderate risk, and >30% high risk). The prediction models for the four different time-points
were validated by applying the regression coefficients into the independent datasets from Denmark
and Scotland. ROC-AUC values for the seventh day model were for the Finnish cohort 0.704 (0.64-
0.755), for the Danish cohort 0.739 (0.666-0.812), and for the Scottish cohort 0.740 (0.646-0.834).
The sensitivity of the seventh postoperative day model at the 20% risk level was 32.8% in the Danish
cohort and 47.4% in the Scottish cohort, and the specificities were 94.4% and 82.4%, respectively.
At the 30% risk level, the sensitivity was 12.1% for the Danish cohort and 26.3% for the Scottish
cohort, and the corresponding specificities were 97.3% and 93.9%. Based on the results of the
prediction models a web-based risk calculator was then developed (Figure 8). The web address for
the developed predictive tool is http://www.hus.fi/breastsurgery/predictivemodel .
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Figure 8. An example of how the web-based pain prediction calculator works. The information of a
hypothetical patient was input and the calculator shows the risk percentages for different follow-
up points.
5.3. PSYCHOLOGICAL FACTORS
The variability between patients in all psychological variables were high throughout the follow-up
period. Table 6 shows the distributions of depressive symptoms (BDI) and state (STAI state) and trait
(STAI trait) anxiety variables at different time-points. All variables are higher preoperatively, and the
mean values remain quite stable from the one-year to the three-year follow-up.

























n 999 840 768 705 987 833 733 677 990 832 725 660
Mean 8.3 7.3 7.4 7.4 40.4 33.0 33.0 32.3 36.9 34.5 34.9 34.4
Media
n
7.0 5.0 6.0 6.0 38.0 32.0 31.0 31.0 35 33.0 33.0 33.0
SD 6.7 6.7 6.8 6.6 11.2 9.9 9.9 9.6 9.5 9.8 10.1 9.8
Range 40 46 47 39 58 59 57 53 55 59 60 53
Min 0 0 0 0 20 20 20 20 20 20 20 20
Max 40 46 47 39 78 79 77 73 75 79 80 73
Abbreviations: BDI = Depressive symptoms, State = State anxiety, Trait = Trait anxiety; 0 = Preoperatively, 12 = At
one year, 24 = At two years, 36 = At three years.
Table 6. Descriptive statistics of the mood scale sum scores in the three-year follow-up.
Anxiety
Anxiety was the most consistent psychological variable predicting higher pain experience. State
anxiety predicted experimental pain sensitivity, both modalities (heat pain 48c° β=0.02, p=0.012;
cold pressure test maximum time tolerated β=-0.43, p=<0.001, and cold pain intensity (15 s)
β=0.032, p=0.002) and analgesic consumption (β=0.002, p=0.003). Higher level of trait anxiety
added a risk for persistent pain at the one-year follow-up (OR 1.02 CI 1.01-1.04)
Depressive symptoms and anger regulation
Depressive symptoms and both state (r=0.72; p<0.001) and trait (r=0.68; p<0.001) anxiety were
highly correlated with each other. Also, state and trait anxiety correlated with each other (r=0.65;
p<0.001). Expectation of postoperative pain was associated with mood factors. Women expecting
severe postoperative pain (NRS 7-10) compared to those expecting no or low pain (NRS 0-3)
reported preoperatively more depressive symptoms (MD 5, IQR 9 vs. MD 9 IQR 10, p<0.001) and
both state (MD 35 IQR12 vs. MD 43 IQR 17; p<0.001) and trait anxiety (MD 34.5 IQR 12 vs. MD 38
IQR14;  p=0.010).  Women  reporting  high  levels  of  anger-out  also  expected  to  have  more
postoperative pain (mean 4.90 vs. 5.76, t=-2.72, p=.007, d= -0.40).
Anger regulation and pain
Anger regulation had a modest association with different pain variables. Anger inhibition (anger-in)
and anger expression (anger-out) were categorized in extremes (1SD +- from the mean) to
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determine differences between low and high pain intensity groups. Women reporting high anger-in
scored higher for experimental heat pain intensity (mean 3.16 vs. 3.80, t=-2.17, p=.031, d= -0.27).
High levels of anger-out were associated with higher pain expectations of postoperative pain (mean
4.90 vs. 5.76, t=-2.72, p=.007, d= -0.40), and the need for a greater amount of oxycodone to achieve
satisfactory pain relief for the first time after surgery (log-transformed mean -1.62 vs. -1.49, t=-3.02,
p=.003, d= -0.33). Linear regression analyses revealed an association between anger-in and heat
pain intensity only until it was controlled for mood. Anger-out was associated with a higher need
for oxycodone and expectation of postoperative acute pain after controlling for mood factors in
multivariate analysis, but controlling for age attenuated the association to non-significance.
 Anger-in was associated with mood factors. Results indicate that the tendency to inhibit anger is
associated with mood factors, especially with depressive symptoms (adjusted means 5.9 vs. 11.6,
p<0.001, ŋ²=0.108). Patients with high anger-in reported significantly more depressive symptoms at
all measured time-points than patients in the low anger-in group (adjusted p<0.001).
Table 7 presents the results of a cross-tabulation of low to high anxiety (STAI state and trait) and
depressive symptoms (BDI) groups from questionnaires acquired preoperatively and at one year
postoperatively. Anxiety is defined as low when the sum score of STAI state and trait is 20-39, and
high when the sum score is over 40. Depressive symptoms are defined as low when the BDI sum
score is ≤18 and high when it is ≥19.
PREOPERATIVE MOOD ONE YEAR AFTER SURGERY
Low High n
Anxiety state Low 90.5 % 9.5 % 453
                                           High 69.4 % 30.6 % 373
Anxiety trait Low 87.3 % 12.7 % 566
                                           High 44.7 % 55.3 % 262
Depressive symptoms  Low 95.0 % 5.0 % 778
                                           High 60.0 % 40.0 % 65
Table 7. Proportions of individuals experiencing low or high symptoms of anxiety and depression
preoperatively and at the one-year follow-up.
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Anger regulation and genetics
In Study VI, genotype association analyses were performed with anger regulation variables (anger-
in and anger-out) and two genotypes were selected, OPRM1 c.118A>G genotype and COMT
c.158G>A (Val158Met). In that study cohort, 595 patients (62.4%) had the A/A genotype of OPRM1
c.118A>G genotype, 316 patients (33.2%) had the A/G genotype, and 35 patients (3.7%) were
homozygous, G/G, for the variant allele. No significant association between OPRM1 c.118A>G
genotype and anger regulation was found. Also, the formed interaction term OPRM1 c.118A>G
genotype X anger-out was not significantly associated with the amount of oxycodone needed for
satisfactory pain relief for the first time after surgery.
The genotype COMT c.158G>A (Val158Met) and anger-out (β=.496, p=.004) were significantly
associated. In women with the A/A genotype (= Met/Met) (n=271) the mean value of anger-out was
one digit lower (8.2) than in women having the G/G genotype (9.2) (n=193). A summary of factors

























































Table 8. Conclusion of factors associated with pain measures.
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6. DISCUSSION
6.1. MAIN FINDINGS
The pain experience constitutes a variety of factors also in breast cancer patients, and the range of
pain sensitivity between individuals is high. Pain sensitivity is not sufficient to explain the complex
experience of post-treatment pain. Of the women treated for breast cancer, 13.5% had developed
clinically significant persistent pain at the one-year follow-up. Since approximately 5000 women are
operated on for breast cancer every year, this means that around 675 new women per year in
Finland are at risk of suffering from persistent pain at one year postoperatively. The survival rate at
five years after surgery was very high (96.2%), highlighting the importance of prevention and
management of treatment-related adverse effects.
The best predictors of pain of any kind, i.e. experimental, acute clinical, or persistent pain, were
found to be quite similar and can be divided into three categories. Pain (other chronic pain
condition, pain in the area of surgery, or the intensity of acute pain), more invasive surgery (axillary
clearance), and psychological distress (mainly anxiety) were found to be consistent predictors of
heightened pain experience. In addition to these, pain expectation and higher need of oxycodone
for obtaining satisfactory pain relief after surgery were associated with higher first postoperative
week pain intensity. Obesity was associated with persistent pain at six months and one year after
surgery. Number of previous operations and smoking cessation were associated with persistent pain
at six months. The adjuvant treatments of radiotherapy and chemotherapy added to the risk for
persistent pain at one year.
Screening tools for preoperative and acute-phase use for identifying women at risk for persistent
pain at six months and one year after breast surgery were developed. The one-year prediction tool
was also validated in two other prospective patient cohorts. With preoperative information, the
sensitivity and specificity for 30% risk of persistent pain were 11.2% and 97.5%, respectively. And,
when information about the acute pain intensity was added to the model, the corresponding
proportions were 16.5% and 95.0%.
The average levels of psychological burden, depressive symptoms, anxiety, and heightened anger
expression or inhibition were surprisingly low. However, there was a group of women whose
distress remained quite stable during the first year. Depressive symptoms were higher at one year
in women with persistent pain. Anger regulation had only a modest independent association with
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pain in this patient cohort. However, anger inhibition was associated with higher depressive
symptoms throughout the three-year follow-up period.
Figure 9. Summary of the main results and predictors of acute and persistent pain after breast
cancer treatments. The most consistent predictors appear in boldface.
6.2. RESULTS IN RELATION TO PREVIOUS STUDIES
6.2.1. EXPERIMENTAL AND PERIOPERATIVE PAIN SENSITIVITY
The overall variability in experimental pain sensitivity between women was high, and this finding is
consistent with earlier studies (Kim et al., 2004; Nielsen et al., 2009; Mogil et al., 1999b; Edwards,
2005). There was a group of women in the experimental cold pressure test whose pain reports
plateaued approximately halfway through the cold pressure experiment. This may reflect
differences in the central pain processing and descending pain modulatory systems such that more
pain-tolerant individuals have more efficient endogenous inhibitory systems that became activated
in the experimental acute pain setting (Yarnitsky et al., 2008). A very significant difference in cold
pressure test tolerance was found between women who expected very intense postoperative pain
(NRS 7-10) and women who expected no or low pain (NRS 0-3). Women expecting only low pain
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intensity tolerated the cold pain test almost twice as long as those who expected much pain. It could
be hypothesized that individuals are quite aware of how sensitive they are to pain stimulus. On the
other hand, these individuals may represent a hypervigilant reaction group towards pain, imagined
or actual, and therefore, the pain is experienced as more intense (Eccleston & Crombez, 1999). It
has been shown in healthy participants that interfering with a negative expectation of pain has
enabled the participants to diminish the pain ratings in experimental cold pain tests (Brown et al.,
2008). Another interesting finding was that there was only a moderate correlation between the two
studied experimental pain modalities (heat and cold). This is a consistent finding with earlier studies,
suggesting that experimental pain sensitivity in not a single entity, and the modality of pain must be
taken into account (Granot, 2009; Nielsen et al., 2009).
Contradictory results regarding the predictive value of experimental pain sensitivity for clinical pain
outcomes  have  been  reported  (Kim  et  al.,  2004).  Either  no  associations  (Kim  et  al.,  2004)  or
associations only with a specific pain modality (Abrishami et al., 2011; Johansen et al., 2014; Granot,
2009) have been found. The association between experimental pain variables and acute
postoperative clinical pain was modest in our study. Rehberg et al. (2017) found in a study with
breast cancer patients that higher pain intensity in a preoperative experimental hot water test was
associated with higher pain intensity during the 48 hour postoperative period. We did not include
experimental pain measures in the acute or persistent clinical pain models since the purpose was to
find clinically feasible predictive factors. However, when univariate associations were tested for this
thesis,  there  was  a  weak  association  between  acute  pain  intensity  and  experimental  pain  (both
modalities, but greater for heat pain) and a small association with heat pain intensity and persistent
pain at one year. This needs to be further examined, but the results are consistent with earlier
studies that modality of pain is an important factor when predicting clinical pain (Abrishami et al.,
2011). This also needs to be controlled for other possible covariates (Lariviere et al., 2002), e.g. other
previous pain conditions (Johansen et al., 2014), mood (Starr et al., 2010; Strulov et al., 2007), and
age (Lautenbacher et al., 2017).
Some contradictory previous findings have been presented regarding the association between
experimental pain sensitivity and persistent postsurgical pain (Granot, 2009). But there are no
studies done with breast cancer patients. A large study of factors predictive for persistent
postoperative pain found that lower cold pain tolerance was associated with persistent postsurgical
pain (Johansen et al., 2014). However, this result became non-significant when other chronic pains
were controlled. The impact of previous chronic pain on experimental pain sensitivity was also seen
in our study. Presence of chronic pain was associated with higher experimental pain sensitivity (both
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modalities). Previous chronic pain of any kind and preoperative pain in the area to be operated was
associated also with higher need for oxycodone in the 20 hours after surgery. These findings
together with the results that the higher number of previous operations was also associated with
experimental pain (heat) sensitivity and with pain at six months postoperatively suggest that
repeated injuries may enhance central sensitization. It may also reflect interpersonal differences in
pain vulnerability (Denk et al., 2014). There may be differences in genetics, brain structures, and
pain modulation that lead to higher pain sensitivity (Denk et al., 2014). In the present study, clinical
factors  tested  explained  only  16%  of  the  perioperative  pain  and  approximately  5%  of  tested
experimental pain sensitivity. This suggests that there are a large number of factors affecting pain
sensitivity in addition to clinically measurable factors.
Anxiety was the most important predictor of experimental pain sensitivity in this study. This finding
was independent of the modality or measure. Also, previous studies have reported that more
anxious individuals, especially women, report more experimental pain (Pan et al., 2008; Starr et al.,
2010; Thompson et al., 2008; Strulov et al., 2007). We found also high pain expectations to be
associated with higher experimental pain sensitivity. Amount of emotional appraisal related to pain
varies widely between individuals (Buckelew et al., 1992; Hadjistavropoulos & Craig, 1994).
Furthermore, it has been suggested that anxiety directs one’s attention to pain-related information
(Keogh & Cochrane, 2002). It is possible that those patients whose automatic emotional reaction to
pain was smaller tolerated more pain and did not report it as being as intense as patients who were
more anxious about the situation. Anxiety and pain expectations can have an effect on descending
pain modulation (Bingel et al., 2012), and they could also explain the associations found in this study.
The differences found in pain tolerance (endogenous pain modulatory systems) could be in part
explained by these differences between patients.
6.2.2	FACTORS	ASSOCIATED	WITH	POST-TREATMENT	PAIN
The factors associated with acute and persistent pain were quite similar. Preoperative pain of any
kind, psychological distress (especially anxiety), and axillary clearance were consistent predictors.
Higher BMI, greater number of previous operations, previous smoking, and received adjuvant
treatments also added to the risk for pain persistence.
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6.2.2.1. Previous pain conditions
The phenomenon that pain predicts pain is a consistent finding in the risk of postoperative pain
outcomes (VanDenKerkhof et al., 2013; Ip et al., 2009; Katz et al., 2009). Higher need for oxycodone
in the acute phase, preoperative pain in the operative area, other chronic pain conditions, and
higher postoperative acute pain intensity plausibly share a common background, explaining why
they have an effect on postoperative pain. Differences in the effectiveness of individual endogenous
analgesia systems may explain some of the differences in postoperative pain (Yarnitsky et al., 2008).
In addition, although self-reports of pain (NRS) have been found to be reliable measures and quite
consistent with brain imaging findings of the activity of brain areas when in pain (Coghill et al., 2003),
our finding that preoperative pain predicted both acute and persistent pain may represent
individual differences in pain reporting. The reports of pain of some patients may consistently be
higher than in others. However, since pain is such a subjective experience and there is no objective
way to measure it, the subjective report of the intensity of pain provided by the patient is the most
important information when evaluating pain. The pain-related predictors that were identified here
may additionally have some unique features predisposing to more pain after breast cancer
treatments.
6.2.2.1.1. Preoperative pain in the area of surgery
The most consistently found risk factor for all measured pain outcomes was the presence of
preoperative pain in the area of surgery. Pain during the first postoperative week and persistent
pain at six months and at one year after surgery were found to be predicted by more intense
preoperative pain in the area of surgery. Preoperative pain has been identified as a predictive factor
in  other  surgery  types  as  well  (Ip  et  al.,  2009;  Gerbershagen  et  al.,  2011;  Gramke  et  al.,  2009;
Hoofwijk et al., 2015; Sommer et al., 2010), and also in breast cancer cohorts (Andersen et al., 2015;
Miaskowski et al., 2012). The explanation for why preoperative pain in the operative area predicts
postsurgical outcomes is partly unclear and is likely multifactorial. It has been hypothesized that in
breast cancer patients preoperative pain can be related to regional inflammation caused by the
tumor (Cabodi & Taverna, 2010). Also, differences in cytokine genes have been proposed to explain
the association (McCann et al., 2012). However, preoperative pain in the area that is known to have
a malignant tumor may also reflect a psychological component of the pain experience in that area.
Pain holds a natural threat value (Eccleston & Crombez, 1999; Vlaeyen & Linton, 2000), and
preoperative pain may reflect the heightened worry and fear due to this known threat. We did not
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study factors explaining preoperative pain per se, but those women who had more preoperative
pain also expected higher postoperative pain and were younger. Preoperative pain may be partially
explained by this heightened awareness towards sensations in the cancer-diagnosed breast and
reveal a hypervigilant reaction towards pain (Eccleston & Crombez, 1999). Kynanou et al. (2013)
found in their study that women with preoperative breast pain reported more depressive symptoms
than their peers without pain. Surprisingly, they did not differ in levels of anxiety (Kyranou et al.,
2013). Preoperative pain is clinically a very easy factor to screen and should not be overlooked.
6.2.2.1.2. Acute postoperative pain
It is important to acknowledge that all persistent pain is initially acute. Factors explaining acute pain
intensity in this study included preoperative pain in the operative area, higher need for oxycodone,
higher psychological distress, and higher pain expectation. Moreover, the intensity of postoperative
acute pain on the first and seventh day predicted persistent pain at one year. As the results of this
and previous studies emphasize, acute pain is an important component in the transition from acute
to persistent pain (Chapman & Vierck, 2016; Hoofwijk et al., 2015; Flecher et al., 2015; Perkins &
Kehlet, 2000), also after breast cancer surgery (Andersen et al. 2015, Bruce et al., 2014; Andersen &
Kehlet, 2011). The acute pain trajectories have shown that an unfavorable pain path increases the
risk for pain persistence in other surgery types (Althaus et al., 2014).  In this study, approximately
half of the patients (49.7%) showed decreasing pain resolution over the first week and almost one-
fifth (19%) of the patients were discharged with pain that was increasing over the week. The
proportion of unfavorable pain paths was slightly higher than in previous studies including different
surgery types (Althaus et al., 2014; Chapman et al., 2011). Associated factors for adverse pain paths
warrant further research in breast cancer patients. In a study by Althaus et al. (2014), unfavorable
acute pain resolution was predicted by depression and anxiety, whereas weaker pain resolution in
the acute phase predicted persistent postoperative pain. The authors hypothesized a link between
psychosocial vulnerability and pain persistence.
The role of acute pain in pain persistence process is most likely a continuum for findings that
preoperative pain of any kind predicts worse pain outcome. The link between these two pain
measures is possibly pain sensitivity (Johansen, 2014) and the function of descending pain inhibition
(Yarnitsky et al., 2008). Insufficient treatment of postoperative acute pain may in some individuals
lead to malfunctions of central pain processing, and thus, to sensitization (Katz et al., 2009). This
highlights the fact that some women should be followed carefully after discharge from hospital
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throughout the acute phase and pain should be treated adequately. Gerbershagen et al. (2013)
discussed in their large cohort study that high acute pain ratings are related not only to the severity
or diversity of tissue trauma, but also to healthcare professionals’ estimates of how painful different
operations are and how well the acute pain phase is treated. Therefore, identification of patients at
the highest risk for severe acute postoperative pain is essential. Surgeries related to breast cancer
are not ranked within the highest acute pain risk procedures (Gerbershagen et al., 2013),
nevertheless, because the long-term adverse consequences are considerable, extra attention
should be paid to these patients.
6.2.2.1.3. Presence of other chronic pain conditions
About one-quarter (24%) of patients reported a preoperative chronic pain condition. Chronic
preoperative pain of any kind has been shown to correlate with persistent pain after various surgical
procedures (Johansen et al., 2012). The mechanism for this is unclear and likely multifactorial.
Chronic preoperative pain may be due to a chronic disease, e.g. fibromyalgia, which is known to
have a high co-occurrence with other pain conditions (Markkula R. et al., 2016). A previous pain
condition may have sensitized the central pain modulatory system, predisposing to persistent pain
after tissue injury. Since pain and psychological factors are known to be bi-directionally related
(Janssen, 2002), it is difficult to rule out the possibility that pain symptoms before the operation
would have had an effect on mood symptoms or vice versa. A prolonged pain condition may weaken
psychological flexibility and affect an individual’s recovery from surgery and how pain is
experienced.
6.2.2.3. Axillary surgery
Axillary clearance is a well-established risk factor for both acute and persistent pain after breast
cancer surgery (Wang et al., 2016; Katz et al., 2005; Andersen & Kehlet, 2011; Andersen et al., 2015).
This may be explained by the more extensive surgery in the axilla, with potential injury to the
sensory intercostobrachial nerve, and by the dissection of lymphatic vessels of the arm, potentially
causing lymphedema (Andersen et al., 2015; Jung et al., 2003 and 2005). However, according to the
results of this study axillary clearance was not associated with a more negative pain resolution over
the first week. Thus, even though the intensity of acute pain initially is higher, it is not significantly
associated with slower recovery during the first week. However, the impact of axillary surgery
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remains important for pain persistence at the one-year follow-up. The variables that were analyzed
varied slightly between the follow-up studies (III-V). The variable of the type of surgery was formed
differently in the first six-month follow-up study (III), which may affect the result that axillary surgery
did not explain pain at six months.
6.2.2.4. Adjuvant treatments
In addition to surgery, adjuvant treatments are a further challenge for recovery from breast cancer.
We found that both radiotherapy and chemotherapy increased the risk for pain in the area of
surgery  at  the  one-year  follow-up.  A  large  meta-analysis  by  Wang  et  al.  (2016)  found  a  strong
association  between  radiotherapy  and  risk  for  pain  persistence  after  breast  cancer  surgery.
Radiotherapy is generally given to all patients with breast-conserving surgery and to patients at high
risk for recurrence after mastectomy. Neuropathic pain is a known complication of radiotherapy for
breast cancer (Cross & Glantz, 2003; Meric et al., 2002), and may contribute to persistent pain. The
brachial plexus, in particular, is vulnerable to radiation and is at risk when the supraclavicular fossa
is included in the radiation field in patients with increased risk of locoregional recurrence (Aebi et
al., 2011; Recht et al., 2001). Adjuvant chemotherapy is given when the risk of recurrence is high.
The chemotherapy agents currently in use differ in their side effect spectrum, and especially the
taxane group of drugs is likely to cause neuropathic pain (Song et al., 2017). Administration of
chemotherapy showed an association with persisting post-treatment pain in this study. Adjuvant
chemotherapy is not a frequently found risk factor for persistent pain. However, a few retrospective
studies  have  reported  chemotherapy  to  be  associated  with  persistent  pain  after  breast  cancer
treatments (Gartner et al., 2009; Sheridan et al., 2012).
6.2.2.5. Body Mass Index (BMI)
The association between pain persistence and high BMI was not linear. However, obesity (BMI >31)
was found to be a risk factor for more severe pain. This has also been previously reported in other
surgery types (Johansen et al., 2014). Higher BMI has been associated with the development of
lymphedema after breast cancer surgery, through which it may have an effect also on pain
persistence (Helyer et al., 2010). Obesity may also render the axillary dissection more difficult to
perform. Obesity has been suggested to be related to a proinflammatory mechanism, which has
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been reported to increase general pain sensitivity (Shi et al., 2010). In a large cohort study, high BMI
was associated with a higher risk of infections after hip arthroplasty (Bozic et al., 2012).
6.2.2.6. Age
Age has been shown to be associated with pain sensitivity (Lautenbacher et al., 2017). In many
studies, younger age has been found to predict higher postoperative pain (Duale et al., 2014;
Montes et al., 2015; Ip et al., 2009). Previous studies with breast cancer patients have described
younger age to be a risk factor for higher pain experience, both acute (Katz et al., 2005; Rehberg et
al., 2017) and persistent (Wang et al., 2016; Miaskowski et al., 2012; Andersen et al., 2015). Age was
not a consistent predictor for pain in the present study. However, in accord with previous studies
oxycodone consumption was higher in younger patients during the 20-hour postoperative period.
This may reflect the pharmacokinetics of oxycodone. It has been reported that oxycodone clearance
slows down with older age (Saari et al., 2012). However, our finding may also reflect pain sensitivity
in  younger  patients.  Lautenbacher  et  al.  (2017) concluded in their systematic review that pain
sensitivity seems to decrease with age, even though pain tolerance does not. We also found that
older  age  (>65  years)  increased  risk  for  higher  pain  at  six  months  after  the  surgery.  A  putative
mechanism behind increased pain in the elderly could be the deterioration of diffuse noxious
inhibitory control (DNIC) with age (van Wijk & Veldhuijzen, 2010). Lariviere et al. (2002) found in
their  study  that  DNIC  begins  to  diminish  already  in  middle  age,  which  may  explain  some  of  the
variance between reported persistent pain and advancing age. The explanation for why younger age
was not a constant predictor of pain in the present cohort is unclear. Younger age was associated
with a variety of psychological factors in our study, e.g. higher pain expectations, state anxiety,
depressive symptoms, lower anger inhibition, and higher anger expression. When age was examined
as the only independent variable, it was associated also with many pain variables. Younger patients
expected significantly more postoperative pain and reported more preoperative pain in the area of
surgery. Hence, one could argue that the meaning of age is represented in those factors that were
found to explain pain outcomes.
6.2.2.7. Gender
One explanation for the high prevalence of persistent pain after breast cancer treatment compared
with many other procedures could be female gender (Bartley & Fillingim, 2013). As Gerbershagen
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et al.  (2014)  pointed out in  their  large cohort  study,  female gender has been shown to be a risk
factor for acute pain in all surgery types. However, breast cancer surgery is not a high-risk procedure
for acute pain (Gerberschagen et al., 2013). Initial acute pain may by more adequately treated after
breast cancer surgery if it is attributed to be a more painful procedure (Alqudah et al., 2010;
Wandner  et  al.,  2010).  Also,  the  malignant  nature  of  the  cause  of  the  surgery  may  add  to  this
attribution.
Since differences between males and females have been shown both in experiencing pain and in
responses to treatment, it is important to conduct research that is gender-specific. Results of the
present study may, therefore, not be generalized to both sexes. Gender may also explain the
differences between the results of the present study and those of Bruehl et al. (2008) regarding the
association of OPRM1 and anger-out interaction in acute pain. Moreover, gender may be an
important moderating factor when genetics are studied (Mogil, 2012b), and should be
acknowledged in statistical analyses.
6.2.2.2. Role of psychological factors in postoperative pain
High variability existed between patients on reports of depressive symptoms and anxiety. A
subgroup of patients reported high levels of symptoms during the follow-up period. It seems that
women who reported higher anxiety or depressive symptoms preoperatively were likely to report
those symptoms also later on. On the other hand, women with low levels of anxiety or depressive
symptoms  were  likely  to  stay  that  way.  There  may  be  some  vulnerability  for  heightened  mood
reactions in some patients after diagnosis, and they also have difficulties in “returning to normal”.
6.2.2.2.1. Pain expectations
Higher pain expectation was found to predict higher acute pain intensity. This finding is in line with
a study done with women about to have a Cesarean section (Pan et al., 2013). However, Rehberg et
al. (2017) found only a univariate association in a breast cancer cohort. In our study, for those
women who expected high pain, the pain also resolved slightly faster during the first week.
However, the clinical significance of this weak statistical association warrants further investigation.
Depressive symptoms, anxiety, and younger age were found to explain higher expectations of pain.
Anger expression did not have an independent contribution. These results are in line with previous
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findings that pain expectations are associated with mood factors, especially anxiety (Pan et al., 2013;
Schnur et al., 2007; Keogh & Cochrane, 2002).
6.2.2.2.2. Anxiety
The presence of anxiety was an important predictor of experimental pain sensitivity, perioperative
analgesic consumption, and acute and persistent clinical pain.  The contribution of anxiety to the
pain experience has been reported also earlier in breast cancer studies (Bruce et al., 2014;
Miaskowski et al., 2012), although studies without an association also exist (Andersen et al., 2015).
Interestingly, in the present study higher state anxiety was associated with acute pain and trait
anxiety in persistent pain.
These results are understandable in light of the definition of these anxiety positions. State anxiety
is characterized by nervousness, tension, and apprehension in a given moment and by arousal and
activation of the autonomic nervous system. Trait anxiety, on the other hand, is defined as a
relatively stable disposition to perceive stressful situations as threatening and to feel discomfort,
stress,  and  worry  (Spielberger,  1983).  The  arousal  of  the  autonomous  nervous  system  in  state
anxiety  is  relevant  also  for  the  pain  experience  (Voscopoulos  &  Lema,  2010).  Also,  rumination
behavior,  stress,  and  fearful  thoughts  related  to  trait  anxiety  are  known  to  predispose  to  pain
persistence (Eccleston & Crombez, 1999; Edwards et al., 2016; Chapman & Vierck, 2016).
The explanation for why anxiety predisposes to pain is most definitely multifactorial. State and trait
anxiety are highly correlated and share naturally common features with respect to pain, e.g.
hypervigilant behavior (Spielberger, 1983). A high correlation was also seen in the present study.
Vulnerability to anxious reactions (trait anxiety) also has an effect on the strength of the state
anxiety reaction. This may be a key element in how anxiety influences the acute pain experience.
An anxious reaction after breast cancer diagnosis is a normal reaction to a stressful situation, and
the finding that all evaluated mood factors were higher preoperatively is understandable and is
supported by earlier research (Begovic-Juhant et al., 2012; Zainal et al., 2013). One could argue that
the “normal” anxious reaction to cancer is not sufficient to heighten the pain experience, but that a
broader susceptibility to anxiety must be present. A study by Starr et al. (2010) reported an result in
healthy participants where a small rise in anxiety was associated with higher experimental pain
tolerance, and it was hypothesized to be a sign of a boost of an individual’s own descending pain
modulation caused by anxiety. None of the participants in that study had clinically significant
depression or anxiety. This is in line with our findings that anxiety may work differently in individuals
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with a proneness to anxious reactions. This finding may be even more pronounced in breast cancer
patients since anxiety is a common reaction to cancer and includes also more cognitive and affective
attribution of the cause of pain. Fear of recurrence of cancer may direct attention more to pain
sensations in the operated area in cancer patients compared with nonmalignant surgeries.
Preoperative psychological factors explained rather modestly pain persistence at the one-year
follow-up. One explanation for this could be that psychological symptoms are already included in
factors related to pain sensitivity, and therefore, these stronger predictors of pain already cover
some of the shared variance. The consistent predictor, preoperative pain in the area of surgery, may
for example be a more acceptable way to express fear and worry about the upcoming surgery and
cancer than reporting anxious feelings. It may also in part represent anxiety sensitivity, as argued
earlier. Anxiety sensitivity is defined as heightened fear and concentration on bodily sensations
(Esteve & Camacho, 2008). We did not study anxiety sensitivity as such, but trait anxiety is known
to be closely related to it (Reiss, 1997). Some researchers argue that these two, anxiety sensitivity
and trait anxiety, highly overlap and represent the same construct (Lilienfeld et al., 1993).
In the screening tool studies (III, V), anxiety and depressive symptoms were divided into diagnostic
categories and did not predict persistent pain. The usage of diagnostic categories loses some
information compared with using continuous variables (Goldberg, 2000). Also, psychological
symptoms, mood or cognitive, are not categories, but rather dimensions. This means that the cut-
offs for the presence of depression or anxiety predefine who has or does not have such symptoms.
A person who scores slightly lower in e.g. a questionnaire of depressive symptoms is defined as “not
having depressive symptoms” when the score stays above the cut-off point. When we want to
explore the relationship between pain experience and psychological factors, the dimensional
approach is more sensitive in determining how these are associated (Goldberg, 2000). This was
proven in this study where trait anxiety predicted persistent pain as a continuous variable, but not
when it was divided into diagnostic categories. The categorization of depressive symptoms and
anxiety, however, was done for two reasons in the screening tool studies. First, the tools were
designed for clinical use where information of the cut-off point for increased risk is needed. The
other reason was that we wanted to validate the second diagnostic tool in two different datasets,
and the use of different questionnaires between studies made the exact comparison difficult.
Therefore, the compromise was to use diagnostic categories of depressive symptoms and anxiety.
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6.2.2.2.3. Depressive symptoms
Depressive symptoms were not an independent predictor of pain in this study. However, for the
predictors for acute pain trajectories, depressive symptoms were combined with reported anxiety
to form a variable to represent overall psychological burden (distress). That aggregated factor was
a good predictor of acute pain intensity. The covariation of psychological symptoms is high (Ball et
al., 2002; Kircanski et al., 2016), but this is rarely acknowledged in breast cancer pain studies
(Andersen et al., 2015; Katz et al., 2005; Rehberg et al., 2017).
We found that higher depressive symptoms at one year were associated with pain experience at
that time. Women with higher pain reported more depressive symptoms. It should be emphasized
that depressive symptoms preoperatively measured did not have predictive value for pain
persistence. However, depressive symptoms were more of an outcome of pain. Previous studies
support this conclusion that depressive symptoms follow rather than precede pain (Knaster et al.,
2012;  Schreiber  et  al.,  2013),  and,  more  importantly,  their  concomitant  presence  makes  the
treatment of both more difficult (Edwards et al., 2016; Gureje, 2008).This finding underlines the
importance of prospective studies so that we may better explain the causalities between mood
factors and pain.
In conclusion, anxiety seems to be a better predictor of pain, whereas depressive symptoms
manifest when the pain has become persistent. Depressive symptoms related to the interference
and threat that pain evokes are understandable and normal reactions (Morley, 2008). Negative
affect and loss of energy, signature features for depression, have an influence on how a person can
handle different stress factors in her life such as ongoing pain.
Symptoms of depression and anxiety are common in breast cancer survivors (Maass et al., 2015),
and depressive symptoms are reported to develop during the first year after breast cancer diagnosis
(Maass  et  al.,  2015).  Lowered  mood  has  an  influence  on  a  variety  of  health-related  factors  and
quality of life (Champion et al., 2014; Lehto et al., 2005; Kokkonen et al., 2017). A recent study
reported that a combination of depressive symptoms and anxiety was quite common at six months
after breast cancer surgery (Gold et al., 2016), and it was associated with several negative outcomes
such as lower performance status, greater difficulty dealing with disease and treatment, and less
perceived support from others. These women also had lower physical and psychological quality of
life, and increased fears of recurrence. Furthermore, female gender and presence of anxiety are
known risk factors for the development of depression (Markkula N et al., 2016). Both of these factors
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were present in this study, and they were also significant for the pain experience. Some studies
suggest that negative emotions may have an unfavorable effect even on cancer survival (Hjerl et al.,
2003; Lehto et al., 2006).
6.2.2.2.4. Anger regulation
It is commonly acknowledged that cognitive and emotional processes, such as anxiety, depression,
and pain expectation, affect pain, but it is not known whether the manner in which a person usually
expresses her anger is meaningful to the pain experience in a breast cancer cohort. The results of
this study imply that anger regulation is more meaningful to mood than to pain outcome in breast
cancer patients. This is the first study done to evaluate anger regulation and both experimental and
post-treatment pain in women with breast cancer. A previous study examining postoperative pain
in male patients found higher anger expression to predict higher pain intensity (Bruehl et al., 2006).
Contradictory findings between anger regulation and other types of pain have also been reported
(Bruehl et al., 2009; Bruehl et al., 2012; Materazzo et al., 2000; Nisenzon et al., 2014; Sayar et al.,
2004).
A variety of factors have been suggested to be meaningful in how anger regulation affects pain.
Gender (Bruehl et al., 2007; Burns et al., 1998), modality of pain (Bruehl et al., 2003; Sayar et al.,
2004),  and  mood  (Knaster  et  al.,  2008;  Burns  et  al.,  2008;  Materrazzo  et  al.,  2008)  are  possible
mediating factors. Anger regulation is considered a rather stable behavioral trait. However, long
follow-up  studies  describing  how  this  trait  evolves  over  the  lifetime  or  during  dramatic  life
experiences,  like  cancer,  are  not  available.  Age  is  rarely  controlled  in  studies  of  pain  and  anger
regulation, and in this study age was found to be an important predictor for how anger is associated
with pain. The result that the association between higher anger expression and higher analgesic
requirement and higher pain expectation was non-significant after controlling for age indicates that
age indeed is an important mediator between anger regulation and pain. Anger expression outward
was more common in younger patients, whereas inhibition of anger was associated with older age.
This is also reported in the theory of anger regulation (Spielberger, 1999). This could indicate that
anger regulation changes with lifetime experiences. Reporting of anger regulation may be biased
due to social expectations. This may also explain some differences between patient groups and age.
Our finding that anger regulation has only a marginal independent effect on pain experience does
not rule out the possibility that it may mediate how e.g. mood factors affect pain, and especially
coping with pain. Ongoing depression is potentially a risk for more perceived pain and disability in
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breast cancer patients (Bruce et al., 2014; Miaskowski et al., 2012). Results of this study suggest a
close relationship between ongoing depression and emotional suppression (anger inhibition) in the
three-year follow-up. Anger inhibition and depressive mood are plausibly parts of the same mood
and  behavior  constellation,  negative  affect  (Burns  et  al.,  2008;  Materrazzo  et  al.,  2008).  Future
research is needed to clarify whether also the tendency to expect higher postoperative pain is part
of this constellation. Expression of negative emotions has been shown to be beneficial for the quality
of life of breast cancer patients (Lieberman & Goldstein, 2006), whereas anger inhibition was found
to be associated with less perceived spousal support in cancer patients (Julkunen et al., 2009). Lack
of partner support and increased depressive symptoms may therefore have a major influence on
how well a person adjusts to her life with treated or ongoing breast cancer and how well she can
manage fearful thoughts and rumination about the recurrence of cancer.
6.2.2.2.5. Anger regulation and OPRM1 rs1799971 (A118G) and COMT rs4680 (Val158Met)
genotypes
Like previous studies (Bruehl et al., 2006; Bruehl et al., 2008), we found no significant direct
associations between OPRM1 rs1799971 genotype and anger expression or anger inhibition. Our
study  did  identify  a  statistically  significant  association  between COMT rs4680 (Val158Met) and
anger expression. The reports of anger expression increased with the number of G allele carriers.
This COMT gene variant has earlier been associated with a history of suicidal attempt (Baud et al.,
2007; Rujescu et al., 2003) and aggressive behavior (Jones et al., 2001). Previous studies assessing
the associations between anger regulation and COMT (Val158Met) have produced conflicting
results (Baud et al., 2007; Rujescu et al., 2003). This is a preliminary finding and needs to be further
investigated. However, it seems that the association of the COMT G/G genotype and anger-out is
stronger in certain patient groups (suicide attempters) (Baud et al., 2007) and that it modulates the
influence  of  environmental  factors  (Perraud  et  al.,  2010).  It  has  been  suggested  that  COMT  Val
carriers may be more vulnerable to epigenetic changes (Perraud et al., 2010). Therefore, early life
stressors may influence emotional regulation and the chosen survival strategy in stressful life-
situations, including pain and cancer.
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6.2.3. PAIN PREDICTION TOOL
Upon identifying the risk factors for pain, the next step is to devise an easy method to reliably screen
women likely to develop a persistent pain condition after breast cancer surgey. This is important in
order to find ways to prevent postoperative pain. Here, two different screening tools were
developed. In the first, preliminary prediction tool study (Study III), the follow-up period was six
months and the independent variables were slightly different compared with the second model
(Study V). In the second study, four different models were developed, and the variables available
after the first week were included in the final model. As the screening tool was developed further,
a consistently shown risk factor, the intensity of acute pain, was included in the model. This second
tool was validated in two different datasets. Therefore, only variables common to all datasets were
chosen for the analyses. Two variables that were important in the preliminary six-month prediction
tool, i.e. previous smoking and number of previous operations, were left out for this reason. Some
compromises, concerning e.g. psychological variables, were also necessary to make the data more
concordant. However, the risk factors for persistent pain were replicated in all datasets:
preoperative pain in the operated area, acute pain intensity, ALND, and obesity. This is the first
study that has validated the developed risk tool.
Development of a diagnostic tool is always a trade-off between sensitivity and specificity. To find as
many patients as possible who will probably develop persistent pain, the tool needs to be sensitive.
On the other hand, high sensitivity comes at the cost of low specificity; i.e. among the selected
women is a subgroup not at risk for persistent pain (false-negatives). The selection of the criteria is
based on the needs of the diagnostic tool. If the intervention is psychological or a more intense
follow-up after breast cancer surgery, sensitivity is more relevant than specificity. However, if the
intervention  is  e.g.  preventive  medication,  specificity  should  be  as  high  as  possible  so  that  the
medication with possible side effects is not targeted to women who do not actually need it. In this
study,  the  model  was  aimed  to  be  as  specific  as  possible.  The  developed  tool  finds  with  a  high
certainty (>90%) those women who are at high risk.
A false-positive prediction may cause anxiety and fear, focusing the patient’s attention on the
surgical area. In the worst case scenario, it may work as a self-fulfilling prophecy, as we know that
expectancy of specific symptoms may sensitize to the development of pain (Atlas & Wager, 2012;
Tracey, 2010; Colloca & Benedetti, 2006). Although, this prediction model does not find all women
at heightened risk (low sensitivity), only few will have false-positive risk estimation.
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Persistent pain after breast cancer treatments may in part arise from a different process than in
other surgeries. Therefore, the developed screening tool may not work universally for all surgery




Measuring psychological constructs is difficult and no matter how well designed a questionnaire is
there is always the possibility of misunderstanding and bias. The psychological questionnaires (BDI,
STAI, and STAXI-II) that were used in this study have not been validated in cancer patients in Finnish
cohorts. However, they have been widely used and found to be reliable and valid scales to measure
these psychological constructs. Their specificity in cancer patients remains unknown. In this study,
trait anxiety was reported to be higher preoperatively than in the follow-ups, even though it should
measure a quite stable behavioral trait. This may suggest that scales designed to measure mood in
a healthy population may perform differently in cancer patients. There is no gold standard regarding
measurements to use in this specific group of patients. However, a study with advanced cancer
patients showed good validity and reliability of measuring depressive symptoms with BDI
(Warmenhoven et al., 2012). No such study exists with a sufficient number of patients for the STAI
scale.
Also, the well-recognized problem of covariation between the scales used brings up the question if
significant predictors of pain persistence dropped out from the models because of this problem.
Covariation between other studied variables, e.g. cancer severity index, surgery type, and adjuvant
treatment, is an unavoidable problem. A strength of this study may also be viewed as a limitation;
we used a wide range of questionnaires to evaluate both pain and psychological variables. It may
be exhaustive for a patient to fill in long questionnaires, which in turn may have an effect on how
reliable the answers are. However, the questionnaires of pain-related catastrophizing or surgical
worry may have brought more information about risk factors for heightened pain experience in this
cohort.
Despite good validity in measuring pain intensity with NRS, it is not an objective measure of pain
and may be sensitive to reporting biases. Cancer patients may either over- or underestimate their
92    | DISCUSSIONPersistent pain after breast cancer treatments may in part arise from a different process than inother surgeries. Therefore, the developed screening tool may not work universally for all surgerytypes, although it definitely includes some of the components that are risk factors for painpersistence more broadly.6.3. STUDY LIMITATIONS6.3.1. QuestionnairesMeasuring psychological constructs is difficult and no matter how well designed a questionnaire isthere is always the possibility of misunderstanding and bias. The psychological questionnaires (BDI,STAI, and STAXI-II) that were used in this study have not been validated in cancer patients in Finnishcohorts. However, they have been widely used and found to be reliable and valid scales to measurethese psychological constructs. Their specificity in cancer patients remains unknown. In this study,trait anxiety was reported to be higher preoperatively than in the follow-ups, even though it shouldmeasure a quite stable behavioral trait. This may suggest that scales designed to measure mood ina healthy population may perform differently in cancer patients. There is no gold standard regardingmeasurements to use in this specific group of patients. However, a study with advanced cancerpatients showed good validity and reliability of measuring depressive symptoms with BDI(Warmenhoven et al., 2012). No such study exists with a sufficient number of patients for the STAIscale.Also, the well-recognized problem of covariation between the scales used brings up the question ifsignificant predictors of pain persistence dropped out from the models because of this problem.Covariation between other studied variables, e.g. cancer severity index, surgery type, and adjuvanttreatment, is an unavoidable problem. A strength of this study may also be viewed as a limitation;we used a wide range of questionnaires to evaluate both pain and psychological variables. It maybe exhaustive for a patient to fill in long questionnaires, which in turn may have an effect on howreliable the answers are. However, the questionnaires of pain-related catastrophizing or surgicalworry may have brought more information about risk factors for heightened pain experience in thiscohort.Despite good validity in measuring pain intensity with NRS, it is not an objective measure of painand may be sensitive to reporting biases. Cancer patients may either over- or underestimate their
pain ratings regarding the attribution of the cause of pain (Smith et al., 1998). Measuring pain is
always a patient’s subjective evaluation of how interfering or severe the pain is. This subjective
rating includes the person’s life history of pain, expectations of pain, and the context in which the
pain is measured (Carlino et al., 2014). This was seen also in this study. Pain expectation influenced
the reporting of pain.
6.3.2. Study protocol
Patients were very intensively attended to by our research nurse pre- and postoperatively. Patients
had the possibility to contact the research nurse if they had problems with pain or recovery. This
may have brought an extra sense of security and may have influenced mood and hypothetically also
pain ratings positively.
6.3.3. Statistical analyses
Statistical significance is not the same as clinical significance. Statistical risk represents the odds of
a risk occurring. However, the reality in a patient’s life is far more complex and unpredictable. In a
study, we cannot control all possible factors that explain, for example, pain persistence. In a
paradoxical way, the most reliable statistical model is one where the independent factors are
reduced to a minimum.  Risk models are often built to contain factors hypothesized to be the most
likely to explain dependent factors. The results thus reflect the factors we have tested, and we most
likely test factors that have previously shown a predictive tendency. Therefore, new statistical
approaches are needed to uncover new predictive factors. For example, the big data analyses
(Gerbershagen et al., 2014) from a large dataset may also yield new perspectives in research of
breast cancer cohorts.
As seen also in this study, the statistical approach applied affects to some extent the results. The
use of categorical versus continuous variables as a dependent variable has an effect, as discussed
earlier. Also, the choice of the regression model may affect the results. The widely used binary
regression model loses some information about the outcome variable. The cut-off limits for risk
versus no-risk groups are often clinically attributed. For example, a cut-off line for clinically
significant pain is often NRS ≥ 4 (Gerbershagen et al., 2011), but in some individuals NRS 3 may have
a significant impact on everyday activities and mood. Therefore, the linear regression model may,
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in some cases, be more sensitive in detecting the dimensional variability of the studied variables.
Both statistical approaches are correct, but the reader needs to be aware of the differences between
the methods.
6.4. STRENGTHS OF THE STUDY
The most important strength of this study is the large number of participants, allowing the use of
multivariate analyses in a reliable way. Other strengths are the carefully described perioperative
and acute postoperative phases and the great number of studied variables and pain and
psychological symptoms. The wide range of pain-related variables, experimental, pre- and
perioperative, and follow-up information, and evaluation of the core of mood factors from the same
individuals give a good picture of these phenomena in this patient cohort.  Another noteworthy
strength is the prospective study design, which allows the study of causalities. Most studies done
with breast cancer patient cohorts are cross-sectional in nature. The prediction tool that was
developed is easy to use in clinical practice and offers a simple way to select women for future
preventive studies. Validation of the prediction tool in two different prospective datasets gives it
reliability.
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The most clinically relevant result of this study was the developed and validated screening
instrument.  Furthermore,  the  risk  factors  identified  for  higher  acute  pain  are  important  to
recognize, and intervention should occur most optimally in the preoperative phase or in the acute
pain phase. This is important for several reasons. Minimizing the suffering of individuals is
paramount. Another reason is that heightened acute pain is a good predictor of pain persistence. A
further concern is treating the pain caused by surgery as well as possible before adjuvant treatments
begin approximately one month postoperatively.
Depressive symptoms and anxiety remained fairly stable “traits” in some individuals in the follow-
up.  The significance of this finding in the pain process warrants further investigations. Perhaps,
instead of only measuring mood factors preoperatively as a predictive factor, a more meaningful
way to elucidate their role in the process of pain becoming persistent would be to follow the change
of mood factors over time at least through adjuvant therapies. The finding that anger inhibition
combined with depression remains stable in a long follow-up suggests this as a possible target for
psychotherapeutic intervention.
Pain expectation explained one part of the difference in pain sensitivity and acute pain intensity.
The role of higher expectation of pain, representing possibly placebo and nocebo effect, is an
important finding for clinical practice. Pain expectation is easy to screen, and by identifying patients
with higher expectations, it is possible to determine its source and to intervene in the expectations.
In addition, healthcare professionals should not enhance these expectations when preparing
patients for surgery. Information about effective medication and the average intensity of acute
postoperative pain after breast cancer surgery is recommended, and sufficient, for most patients.
However, the close relationship between anxiety and pain expectation suggests that some patients
would benefit from psychological consultation. Anxious women, with preoperative pain and high
expectations of postoperative pain could be a target for intervention. Psychological interventions
could include, for example, training to acknowledge the habit of negative thinking, expectations,
and biased attention towards pain. Future research is needed to see if managing these risk factors
for higher pain experience could lower the risk of their mediating role in the path of pain persistence
and potential development of depression.
The mood scales used in this study were time-consuming to fill in and were not specifically designed
for this patient group, and therefore, may not have been selective enough in this cohort.
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Psychometric research of different scales is a very important target for future studies. Selection of
the best and most targeted questions of all scales used could more specifically find those
psychological dimensions that are important for pain experience and its persistence in this patient
group. Different psychological factors, e.g. catastrophizing and surgical fear, should also be included
in the models. The fear of recurrence may bring its own challenge in this group of patients and may
have an effect on the descending modulation of pain through anxiety, fear, and negative
expectations.
There is still much that we do not know about the pain experience and its persistence in women
treated for breast cancer. The experimental pain tests revealed groups of high and low pain-tolerant
individuals. Closer study of the underlying factors related to the hypothesized more efficient
endogenous descending pain mechanisms could bring new knowledge about pain modulation in this
cohort and, more importantly, how this is related to the risk of pain persistence. However, this study
gives good perspectives for designing new research in this field. Therefore, the developed risk tool
should be used in future studies to find new predictive factors. Prospective studies with longer
follow-up periods are needed to see how pain and the factors associated with persistence plausibly
evolve. We now know that breast cancer and pain related to its treatments are risks for lowered
mood. The next step would be to clarify how trajectories of mood changes after breast cancer
surgery impact on pain in post-treatment years.
We focused on risk factors in this study. Future studies should also focus more on those factors that
are protective of pain persistence, in other words, to determine a balance between vulnerability
and resilience factors. After all, the majority of women after breast cancer treatments do not
develop any pain condition. The information of the protective factors behind a favorable pain path
may also help those women who are at risk of developing a pain condition. Many women will have
all the risk factors and still will not develop persistent pain. It is therefore important to be aware
that studies merely describe the statistical risk for pain. However, an individual patient is far more
complex to predict.
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Conclusions to study aims:
1. Experimental pain sensitivity varied widely between women undergoing surgery for breast cancer.
The modality of experimental pain seems to be important when examining the association between
experimental pain and clinical factors. Higher level of state anxiety and previous pain condition were
significant variables explaining both experimental pain sensitivity (regardless of modality) and
postoperative analgesic consumption. Younger patients were more sensitive to postoperative pain
measured by the amount of required analgesics. However, age did not explain the variety in
experimental pain sensitivity.
2. Risk factors for higher pain experience, both acute and persistent, in breast cancer patients were
identified and found to be quite similar. More invasive surgery, presence of preoperative pain (other
chronic pain or pain in operative area), and mood, especially heightened anxiety, were the most
consistent predictors of pain experience. Expectation of higher postoperative acute pain predicts
higher  acute  pain  intensity.   Obesity  and  received  adjuvant  therapies  were  associated  with
persistent pain. Also the intensity of acute pain predicted higher pain intensity at one year. The
meaning of previous pain in pain experience after breast cancer treatment is an important clinical
observation since chronic pain due to several reasons is common, especially in females. Pain
tolerance or threshold from experimental pain is not enough to explain the complex process of
either acute or persistent postoperative pain.
3. Psychological symptoms, anxiety, depressive symptoms, and pain expectation are linked to the pain
experience in women with breast cancer. State anxiety seems to be particularly relevant to
heightened acute pain experience and analgesic use, whereas trait anxiety is meaningful for pain
persistence. Anxiety variables are highly correlated, which leads to the conclusion that overall
proneness to anxiety is important for heightened pain experience. Depression, however, did not
have an independent predictive value for heightened pain experience, although it was more
common at one year in women with persistent pain. The contribution of anger regulation to the
pain experience was modest in this patient group. However, anger inhibition is closely associated
with depressive symptoms and is therefore important to recognize. The presence of anxiety is
  Pain Sensitivity and Factors associated with the Pain Experience after Breast Cancer Treatments  |    97   8.  CONCLUSIONSConclusions to study aims:1. Experimental pain sensitivity varied widely between women undergoing surgery for breast cancer.The modality of experimental pain seems to be important when examining the association betweenexperimental pain and clinical factors. Higher level of state anxiety and previous pain condition weresignificant variables explaining both experimental pain sensitivity (regardless of modality) andpostoperative analgesic consumption. Younger patients were more sensitive to postoperative painmeasured by the amount of required analgesics. However, age did not explain the variety inexperimental pain sensitivity.2. Risk factors for higher pain experience, both acute and persistent, in breast cancer patients wereidentified and found to be quite similar. More invasive surgery, presence of preoperative pain (otherchronic pain or pain in operative area), and mood, especially heightened anxiety, were the mostconsistent predictors of pain experience. Expectation of higher postoperative acute pain predictshigher  acute  pain  intensity.   Obesity  and  received  adjuvant  therapies  were  associated  withpersistent pain. Also the intensity of acute pain predicted higher pain intensity at one year. Themeaning of previous pain in pain experience after breast cancer treatment is an important clinicalobservation since chronic pain due to several reasons is common, especially in females. Paintolerance or threshold from experimental pain is not enough to explain the complex process ofeither acute or persistent postoperative pain.3. Psychological symptoms, anxiety, depressive symptoms, and pain expectation are linked to the painexperience in women with breast cancer. State anxiety seems to be particularly relevant toheightened acute pain experience and analgesic use, whereas trait anxiety is meaningful for painpersistence. Anxiety variables are highly correlated, which leads to the conclusion that overallproneness to anxiety is important for heightened pain experience. Depression, however, did nothave an independent predictive value for heightened pain experience, although it was morecommon at one year in women with persistent pain. The contribution of anger regulation to thepain experience was modest in this patient group. However, anger inhibition is closely associatedwith depressive symptoms and is therefore important to recognize. The presence of anxiety is
important to screen because it is associated with pain sensitivity and more intense pain experience.
Depression most likely persists in individuals with difficulties in expressing negative emotions such
as anger.
4. Clinically feasible predictive tools to screen women at risk for persistent pain were developed. The
prediction tool with a one-year follow-up and with all available women was validated in two
separate cohorts. The absence of psychological factors in risk models does not mean that they are
not relevant to pain.
Better knowledge of singular risk factors will help us to understand why some patients are more
vulnerable to pain persistence than others. The developed models explained only a portion of the
persistent pain, highlighting the importance of continuous research in this field. New treatments to
prevent the progression of the undesirable pain path from preoperative through acute to persistent
should be studied. Future research should elucidate why when many/all of the risk factors are found
in some women, the risk is actualized in only a portion.
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